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vAbstract
The first choice of management is medical treatment in ulcerative colitis (UC). UC is 
limited to the rectum and colon and can therefore be cured surgically in case of failure 
of medical therapy or if there is a risk of cancer. Traditionally it has been estimated 
that approximately 30% of UC patients will require surgery at some point. Preliminary 
population-based studies suggest lower rates of surgery in the era of new biological 
medication. Restorative proctocolectomy (RPC) and ileal pouch-anal anastomosis (IPAA) 
is the preferred procedure for most UC patients. With this operation permanent stoma is 
avoided and an acceptable bowel movement frequency can be achieved.
The main goal of IPAA surgery is high quality of life without permanent enterostomy 
and there is evidence that high volume units and surgeons achieve better results. Not only 
the surgery itself but also the postoperative complications and their care may have serious 
effects on the functional outcomes of these patients and therefore also on health-related 
quality of life (HRQoL). This thesis aimed to study the surgical outcomes of IPAA patients 
in the second biggest centre performing IBD surgery in Finland, Tampere University 
Hospital.
The first study examined how our surgical technique has evolved since its introduction 
in 1985. Indications for surgery and early and late morbidity after surgery are reported. 
We changed our anastomosis technique from hand-sewn to stapled anastomosis and the 
use of covering ileostomy has become a standard. Indications for surgery were acute colitis 
45%, chronic colitis 48% and cancer or risk of cancer 7%. In our results, the serious pouch 
complications were comparable to those reported in the literature, with leakage occurring 
in 12.5%. We found that the use of covering ileostomy seemed to protect against major 
complications. 
The second and third studies consist of questionnaires evaluating HRQoL and the 
functional outcomes of the IPAA patients. The generic Finnish 15D questionnaire was used 
to compare IPAA patients to general population. The majority of the patients had HRQoL 
comparable to that in general population. The disease-specific IBDQ questionnaire was 
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used to compare IPAA patients to non-operated UC patients not undergoing surgery. 
IPAA patients with good functioning pouch had HRQoL similar to those with non-
operated UC patients in remission or with mildly active disease. 
The functional outcomes were assessed by Öresland score. These were good for the 
majority (70%) of patients and remained stable over time. No statistically significant 
connection was found between early pouch complications and poor pouch function. 
Anastomosis stricture was twice as common in poorly functioning pouches as in well-
functioning pouches. 
The fourth part of the study is concerned with pouch failure rate. The reasons for this 
and the life cycle of the pouch were analysed. We found that out of 491 IPAA patients, 53 
(10.8%) experienced pouch failure (10 women, 43 men). Half of the pouch failures occurred 
within the first five years and 70% within seven years of IPAA surgery. The typical reasons 
for pouch failure were septic events that led to poor function. No reasons were found to 
account for the preponderance of men in the failure group. In patients who had Crohn´ s 
disease diagnosed after IPAA 47% experienced pouch failure. We also explored the pouch 
excision operations, of which were 52 (98% of pouch failures) and found that morbidity 
after the operation is common but complications mainly minor in nature. 
In conclusion, this thesis is a comprehensive research entity on long-term IPAA surgical 
results for UC in a tertiary referral centre in Finland. The results for complications after 
surgery and the functional outcomes of the J-pouches and HRQoL are in line with earlier 
reports and the technique we use is justifiable. 
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Tiivistelmä
Haavaisen paksusuolen tulehduksen ensilinjan hoitomuoto on lääkehoito. Tauti rajoittuu 
paksu- ja peräsuoleen ja on sen vuoksi parannettavissa leikkauksella. Perinteisesti on arvioi-
tu, että noin 30% potilaista tarvitsee kirurgiaa jossain vaiheessa sairautta. Viimeaikaiset 
ensimmäiset väestöpohjaiset tutkimukset viittaavat kirurgisen hoidon vähentyneen 
biologisten lääkkeiden aikakaudella. Tavallisin leikkausmenetelmä on paksu- ja peräsuolen 
poisto ja ileumista rakennettu J-pussi ja ileoanaalinen anastomoosi (IPAA). Tällä 
leikkauksella vältetään pysyvä suoliavanne ja saavutetaan yleensä hyvä toiminnallinen 
tulos ja elämänlaatu.
J-pussileikkauksella ja etenkin sen jälkeisten mahdollisten komplikaatioiden hoidolla 
voi olla kauaskantoiset seuraamukset J-pussin toiminnallisiin tuloksiin ja sitä kautta 
elämänlaatuun. Tämän väitöskirjan tarkoitus on raportoida J-pussileikkausten tulokset 
Tampereen yliopistollisessa sairaalassa (TAYS), joka on Suomen toiseksi suurin IBD 
kirurgiaa suorittava keskus.
Väitöskirjan ensimmäisessä työssä tarkastelimme, miten käyttämämme kirurginen 
tekniikka on kehittynyt alun 1985 jälkeen. Raportoimme myös indikaatiot leikkaukseen 
sekä leikkauksen jälkeiset varhais- ja myöhäisvaiheen komplikaatiot. Olemme 
siirtyneet saumanteon tekniikassa alkuperäisestä käsisaumasta saumauslaitteella 
tehtävään anastomoosiin. Suojaavan avanteen teosta on tullut standardi. Indikaatiot 
J-pussileikkauksiin olivat akuutti koliitti 45 %, krooninen koliitti 48 % ja syöpä tai 
syöpäriski 7 %. Tuloksemme komplikaatioiden suhteen on verrattavissa kirjallisuudessa 
esitettyihin lukuihin. Anastomoosin lekaasiprosentti oli 12,5 %. Havaitsimme, että 
suojaavan ileostooman käyttö näytti suojaavan merkittävimmiltä komplikaatioilta.
Toinen ja kolmas työ olivat kyselytutkimuksia, joissa selvitettiin J-pussipotilaiden 
elämänlaatua ja J-pussin toiminnallisia tuloksia. Valtaosalla J-pussipotilaista havaittiin 
olevan yhtä hyvä elämänlaatu kuin väestöllä, yleisellä 15D elämänlaatukyselyllä mitattuna. 
Sairausspesifisellä kyselyllä mitattuna havaitsimme, että niillä potilailla, joiden J-pussin 
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toimi hyvin, elämälaatu oli vastaava kuin leikkaamattomilla potilailla, joiden sairaus 
remissiossa tai taudinkuva lievä. 
J-pussin toiminnallinen tulos tutkittiin käyttämällä Öreslandin kaavaketta. J-pussien 
toiminnalliset tulokset olivat hyvät 70 %:lla potilaista pitkässäkin seurannassa. Hyvin 
ja huonosti toimivien pussin välillä ei löytynyt tilastollisesti merkittävää eroa IPAA 
leikkauksen jälkeisissä varhaisissa J-pussi-komplikaatioissa. Anastomoosin striktuura oli 
lähes kaksi kertaa yleisempi huonosti toimivien pussien potilailla kuin hyvin toimivien. 
Neljännessä työssä tutkimme mikä on leikkaamiemme J-pussien poistoprosentti, 
katsoimme syitä pussien poistoon ja analysoimme pussien elinkaarta. Havaitsimme, että 
491:stä J-pussipotilaasta 53 (10,8 %) pussi oli poistettu käytöstä; naisia 10 ja miehiä 43. 
Tyypillisimmät syyt poistoon olivat tulehdukselliset tapahtumat, jotka johtivat J-pussin 
toiminnan huononemiseen. Syytä siihen miksi pussinpoisto oli yleisempää miehillä ei 
löytynyt. Potilaat, joilla diagnosoitiin Crohnin tauti J-pussin teon jälkeen, 47 %:lla pussi 
ei ollut enää käytössä. Yhdellä potilaalla pussi jäi paikoilleen, mutta muilta 52 (98 %) 
potilailta pussi poistettiin kirurgisesti. Sairastavuus pussinpoistoleikkauksen jälkeen oli 
melko yleistä, mutta vakavia komplikaatioita oli vähän. 
Tässä väitöskirjassa selvitetään J-pussileikkauksen pitkäaikaistuloksia isossa 
suomalaisessa keskuksessa. Yhteenvetona voimme sanoa, että sairaalamme J-pussikirurgian 
tulokset niin leikkauskomplikaatioiden, kuin J-pussin toiminnallisten tulosten kuin 
elämänlaadunkin suhteen ovat hyväksyttävät ja tekniikkamme perusteltua. 
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1 Introduction
Inflammatory bowel diseases (IBD) are divided into ulcerative colitis (UC), Crohn’s 
disease (CD), unspecified inflammatory bowel disease (IBDU) and indeterminate colitis 
(IC) which are chronic inflammatory conditions of the gastrointestinal tract. The aetiology 
is unknown but is thought to be multifactorial (Ananthakrishnan, 2015). IBD may be 
associated with considerable morbidity and may also require expensive healthcare. 
UC is restricted to the large bowel and rectum. Inflammation starts from the rectum 
and extends proximally in a continuous manner to a variable length. Clinical features of 
UC include bloody diarrhoea and abdominal pain. The clinical course of the disease is 
often relapsing (Baumgart & Sandborn, 2007). 
UC is a global disease but the incidence varies geographically. The incidence is 
highest in the westernized countries and still rising. A North-South gradient has been 
identified for IBD and in Europe the highest incidence rates are in Northern countries. 
(Ananthakrishnan, 2015) 
Patients with long-lasting UC are at increased risk of colorectal cancer (CRC). Chronic 
inflammation is an important factor in the pathogenesis of CRC. Young age at diagnosis, 
extensive disease and primary sclerosing cholangitis (PSC) have been shown to increase the 
risk. (Keller et al., 2019.) 
The treatment of UC is primarily medical, although surgery is required in about 30% 
of patients. There is new population-based data to suggest that the percentage requiring 
surgery may be falling in the era of biological medication (Frolkis et al., 2013; Ronnblom et 
al., 2016). Indications for surgery are acute drug resistant disease, chronic refractory disease 
or cancer or risk of cancer. When surgery is considered a multidisciplinary approach in 
collaboration between the gastroenterologists and colorectal surgeon looking after the 
patient is essential.
In 1978 Parks and Nicholls introduced the ileal pouch anal anastomosis (IPAA) (Parks 
& Nicholls, 1978). Restorative proctocolectomy (RPC) with a J-pouch attached to the 
dentate line replaced previous techniques and offered the patients the option of a stoma-
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free life with acceptable bowel movement frequency. This operation has become the most 
used in UC surgery and is suitable for most patients. Over the four decades of J-pouch the 
operation has undergone refinements in surgical technique. Even so, it is still associated 
with significant morbidity and failure (Sagar & Pemberton, 2012). 
This thesis aimed to evaluate the overall long-term surgical outcome of Finland’s second 
biggest centre performing pouch surgery for UC. The specific aims were to evaluate the 
evolution of the surgical techniques used and changes in these, to evaluate the long-term 
health-related quality of life (HRQoL) and functional results of the IPAA patients operated 
on in our hospital and finally to evaluate the percentage of pouch failure and analyse the 
reasons for this. 
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2 Review of the Literature
2.1 Ulcerative colitis
The 1875 case report of Wilks and Moxon describing ulceration and inflammation of 
the entire colon in a young woman who had died of severe bloody diarrhoea was an early 
instance of UC (Kirsner, 2001). 
In UC, the inflammation is restricted to the large intestine. The inflammation may be 
limited to rectum but may also involve the entire colon. UC is characterized by a relapsing 
and remitting course (Silverberg et al., 2005). The disease may present at any age, but occurs 
more often in the second or third decade of life with another peak suggested in the 60s. 
Men and women are equally affected (Ananthakrishnan, 2015).
The chronic nature of UC exerts a major burden on patients in burden of therapy, 
hospitalizations, surgery, health-related quality of life, economic productivity and social 
functioning. 
2.1.1 Epidemiology and aetiology
The incidence and prevalence of UC have increased worldwide in the past 50 years and 
over the last 15 years also in developing countries (Cosnes et al., 2011). High prevalence of 
UC has been reported in Northern Europe (Manninen et al., 2010; Jussila et al., 2013), the 
United Kingdom and North America (Bernstein et al., 2006; Molodecky et al., 2012). The 
incidence of UC varies geographically. A North–South gradient has long been known for 
UC. In Europe, higher incidence rates have been found in Northern countries (Shivananda 
et al., 1996). In Finland a population-based study showed the highest reported incidence 
of 24.8 per 100,000 (Jussila et al., 2012) and a north-south gradient of prevalence has been 
reported (Jussila et al., 2013). 
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The precise aetiology for UC is unknown. The current hypothesis is a dysregulated 
mucosal immune response to commensal gut flora in genetically susceptible individuals 
(Xavier & Podolsky, 2007). Support for a role for genetics in the pathogenesis of IBD was 
initially derived from familial aggregation studies and twin studies, which suggested an 
important hereditary component (Ananthakrishnan, 2015). Since the identification first 
of a IBD risk gene in 2001, over 200 risk gene loci involved in IBD pathogenesis have been 
identified. The risk genes identified are those involved in regulating innate and adaptive 
immune responses or intestinal barrier functions. This strongly suggests that, in addition 
to genetics, the intestinal microbiota and environmental factors also play a critical role in 
IBD pathogenesis (Zhou et al., 2017; Ananthakrishnan et al., 2018).
Patients with IBD demonstrate a dysbiosis in their luminal microbiota, most 
consistently characterized by a reduction in the diversity of this microbial community 
compared with that in healthy individuals (Nagalingam & Lynch, 2012; Zhou et al., 2017; 
Ananthakrishnan et al., 2018). This could render the host more susceptible to colonization 
with pathogens (Ananthakrishnan et al., 2018). 
Potentially relevant environmental influences start from mode of childbirth and early-
life exposures to exposures later on in adulthood (Ananthakrishnan, 2015) Smoking 
and appendectomy have been shown to have a negative impact on the risk of developing 
UC (Lowenfels & Maisonneuve, 2001; Mahid et al., 2006; Myrelid et al., 2017). The use 
of antibiotics has been reported to correlate with IBD incidence. Nevertheless, the role 
of antibiotics seems to be more evident in CD than in UC (Shaw et al., 2011). Other 
medications have been thought to be associated with IBD including nonsteroidal anti-
inflammatory drugs (NSAIDs), oral contraceptives and postmenopausal hormone therapy 
(Ananthakrishnan, 2015; Piovani et al., 2019). In studies concerning dietary factors in 
the risk of IBD, high dietary intakes of total fats, dietary n-3 polyunsaturated fatty acids, 
omega-6 fatty acids and meat are reportedly associated with an increased risk of UC. High 
vegetable intake was associated with decreased UC risk (Hou et al., 2011; Piovani et al., 
2019). 
2.1.2 Clinical presentation and diagnosis
UC is a relapsing non-transmural inflammatory disease that is restricted to the rectum 
and colon. UC primarily presents in late adolescence and early adulthood, although the 
diagnosis may be made at any age. Depending on the anatomic extent of involvement, 
patients can be classified as having proctitis, left-sided colitis (involving the sigmoid colon 
with or without the involvement of the descending colon), or pancolitis. The diagnosis 
is based on the clinical picture, endoscopy and histopathology findings (Baumgart & 
Sandborn, 2007). The most used classification system for UC is the Montreal classification, 
which takes into account the extent and severity of the disease (Silverberg et al., 2005). The 
Montreal classification is presented in Table 1. 
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Typical UC symptoms consist of bloody diarrhoea, passage of mucus and abdominal 
cramping during bowel movements. Severe attacks of illness present as fever, tachycardia, 
weight loss, abdominal distension or reduced bowel sounds. Patients with toxic megacolon 
usually have continuous bleeding, need for blood infusion, abdominal pain and tenderness 
and colonic distention in imaging. Severe symptoms are less common in left-sided colitis 
and proctitis. (Baumgart & Sandborn, 2007). In clinical practice, disease activity is typically 
described as mild, moderate or severe based on the severity of symptoms as mentioned 
above. (Kornbluth et al., 2010). 
The endoscopic features of mild inflammation are erythema, vascular congestion, and 
partial loss of the visible vascular pattern. Moderately active colitis is characterized by a 
complete loss of vascular pattern, blood adhering to the surface of the mucosa and erosions, 
often with a coarse granular appearance and mucosal friability that bleeds on being lightly 
touched (Magro et al., 2017). 
UC is a chronic inflammatory process limited to the mucosa. The microscopic features 
can be divided into mucosal architecture, lamina propria cellularity, neutrophil granulocyte 
infiltration, and epithelial abnormality (Magro et al., 2017). 
?????????????????????????????????????????????????????
(Silverberg et al., 2005)
Extent of the disease Anatomy
E1 Ulcerative proctitis Involvement limited to the rectum
E2 Left sided UC (distal UC) Involvement limited to a proportion of the colorectum distal to the ??????????????
E3 Extensive UC (pancolitis) ????????????????????????? ????????????????????????
Severity ?????????
S0 Clinical remission Asymptomatic
S1 Mild UC Passage of four or fewer stools/day (with or without blood), absence of ??????????????????????????????????????????????????????????
S2 Moderate UC Passage of more than four stools per day but with minimal signs of ?????????????????
S3 Severe UC
???????????????????????????????????????????????????????????????????????
beats per minute, temperature of at least 37.5°C, haemoglobin of less 
than 10.5 g/100 ml, and ESR of at least 30 mm/h
ESR, erythrocyte sedimentation rate
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2.1.3 Medical therapy
Medical therapy is the first treatment of choice for UC. The pharmacodynamics, indications 
used to treat UC are summarized in Table 2. The treatment strategy for UC is mainly based 
on the severity, distribution and pattern of the disease (Harbord et al., 2017). The extent of 
inflammation influences the patient’s management and the choice of delivery system for a 
given therapy. Suppositories or enemas are usually the first-line choice for proctitis and left-
sided colitis respectively, whereas oral therapy is appropriate for extensive colitis (Magro et 
al., 2017). Currently the goal in medical therapy for UC is to induce and maintain remission 
both clinically and endoscopically that is mucosal healing (Boal Carvalho & Cotter, 2017). 
Current treatment options for UC include 5-aminocylic acids (5-ASAs), like 
sulphasalazine and mesalamine in both oral and rectal formulations, corticosteroids, 
thiopurines, calcineurin inhibitor (cyclosporine), anti-tumour necrosis factor (TNF)-α 
drugs (including infliximab, adalimumab and golimumab), more recently the anti-integrin 
drug vedolizumab and most recently tofacitinib, Janus kinase (JAK)-inhibitor (Feagan et 
al., 2013; Harbord et al., 2017; Antonelli et al., 2019). 
The medical therapy can be divided into induction therapy and maintenance therapy. 
Induction therapy is tailored individually depending on the classification of the disease. 
Maintenance therapy is recommended for all patients with UC. (Magro et al., 2017.) 
Striking differences in the frequency, timing and degree of mucosal healing may be found 
in different UC patients, even under similar pharmacological approaches, underlining the 
importance of several genetic, epigenetic, environmental and microbiotic factors in this 
process (Rieder et al., 2012). 
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Table 2. Medications used in the treatment of ulcerative colitis
?????????????????????????????????????????????
Medications Mechanism Indication
Aminosalicylates: 
mesalamine and 
sulphasalazine p.o. 
or topical
??????????????????????????????
effect
– topical: proctitis and mild to moderate left 
sided colitis
??????????????????????????????????????????
– inducing and maintenance of remission
Corticosteroids ??????????????????????????
????????????????????????????
?????????????????????????????
?????????????????
??????????????????????????????????????????????????
disease inducing remission
– mild active disease with no response to 
mesalamine inducing remission
??????????????????????????????????????????????
Thiopurines: 
Azathioprine and 
mercaptopurin
???????????????????????????
??????????????????????????
??????????????????????????????????????????
?????????????????????????????????????????????
– inducing and maintenance of remission
Calcineurin inhibitor: 
cyclosporine
Immunosuppressant: effect 
on division and function of 
?????????????????
– second line therapy in acute severe colitis
?????????????????????
Anti-TNF alpha: 
?????? ????
adalimumab 
?????????????????????????????
??????????????
??????????????????????????????????????????
disease alone or combined with thiopurine
??? ????????????????????????????????
– inducing and maintenance of remission
???????? ???????????????????????????????????????
in acute colitis
anti-integrin: 
Vedolizumab
?????????????????????????????????? ????????????????????????????????????????
– inducing and maintenance of remission
JAK-inhibitor: 
Tofasitinib
?????????????????????????
?????????????????????????????????
????????????????????????????
– moderate to severe colitis if prior biological 
treatment fails
– inducing and maintenance of remission
2.2 Surgery for ulcerative colitis
Traditionally approximately 30% of UC patients have required surgery at some point 
(Hendriksen et al., 1985). Over the past 25 years, medical therapy for IBD has changed 
with the widespread use of immunosuppressive therapy and the introduction of anti-TNFα 
therapy and other biologics. Recent population-based studies demonstrate that the rates for 
surgery are decreasing (Frolkis et al., 2013; Ronnblom et al., 2016). A recent population-
based study reported 5-, 10-, 15-, and 20-year cumulative colectomy rates after diagnosis 
to be 4.1%, 6.4%, 10.4% and 14.4% respectively (Parragi et al., 2018). A Finnish study 
reported lower colectomy rates but no change in indication for surgery before and during 
the biologics era (Kolehmainen et al., 2019). As to the new drugs (anti-integrins and JAK 
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inhibitors), studies are needed to show the trend (Olivera et al., 2017). The indications for 
surgery are fulminant colitis, chronic colitis with relapsing symptoms or cancer or risk of 
cancer. The risk of CRC over time especially in active chronic inflammation, approach risk 
level of up to 18% in 30 years (Eaden et al., 2001). Contraindications for pouch surgery are an 
incompetent sphincter mechanism and carcinoma in the lower rectum requiring excision 
of the anorectum. CD is generally contraindicated (Chang et al., 2017). A multidisciplinary 
approach between the gastroenterologists and colorectal surgeons looking after the patient 
is essential when considering surgery (Öresland et al., 2015). 
2.2.1 History
Surgical treatment of UC emerged in the early 1900s but was initially sporadic and mostly 
experimental. Appendicostomy, caecostomy, and colostomy with colonic irrigations sought 
to eliminate a “noxious substance”. “Pelvic autonomic neurectomy” and distal vagotomy 
in the 1950s were futile efforts to correct “parasympathetic overactivity” (Kirsner, 1998). 
Subtotal colectomy with ileorectal anastomosis and partial colon resections during the 
1950s and 1960s were discontinued because of recurrent disease (Kirsner, 1998). In the 
1950s Bryan Brooke developed a better functioning everted end-ileostomy connected to 
one-stage proctocolectomy and this remained the surgical standard for many years (Parc et 
al., 1999). He stated that “if surgery is to be acceptable for UC it first must be reasonably safe 
and have a mortality lower that of the disease itself (22–33%)”. He specified the indications 
for surgery and proposed that the surgery be done in stages depending on the nutritional 
and general condition of the patient (Brooke, 1952).
In 1969 a continent ileostomy (Kock pouch) was first described by Kock and was 
considered a major improvement over the conventional end ileostomy (Kock, 1969). 
Continent ileostomy allows planned evacuation of the small bowel through a reservoir 
equipped with a nipple valve and patients can live without an external appliance for stool. 
Today, continent ileostomy studies have revealed that this procedure has many short and 
long-term complications, mainly related to the valve mechanism. Despite many revisions, 
patients who retained their pouch were very satisfied and considered their quality of life 
to be good or excellent (Nessar & Wu, 2012). There are some centres, like the Cleveland 
clinic, which still perform continent ileostomy for certain indications but only a handful of 
surgeons familiar with the procedure can be found in practice (Aytac et al., 2014).
The description of IPAA in 1978 by Parks and Nicholls, however, quickly displaced 
the Kock pouch from a position of prominence in the surgical treatment of patients with 
UC (Parks & Nicholls, 1978). Nissen first described an ileal anal anastomosis as early as in 
1933 but it was not until Parks and Nicholls created the ileal reservoir in the anastomoses 
that the functional results began to be acceptable (Parks & Nicholls, 1978). At first there 
were experiments with different shapes of pouches (Figure 1.) but today the J-pouch is the 
most used because it is straightforward to construct and has the fewest stapled lines and its 
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volume is suitable to allow acceptable function (Lovegrove et al., 2007; McCormick et al., 
2012).
2.2.2 Surgical anatomy
The large intestine is approximately 1.5m long and consists of cecum, vermiform appendix, 
ascending, transverse, descending and sigmoid colon and rectum, Figure 2. The ileum 
enters the cecum obliquely and partly invaginates into it forming the ileocecal valve. This 
valve portions the ileal fluid into colon. The large intestine borders on the abdominal 
cavity below the liver, stomach and spleen. The ascending and descending colon lie 
retroperitoneally along the right and left sides of the abdominal cavity. The transverse colon 
is mobile and hangs down as a loop to a variable extent. The sigmoid colon is an S-shaped 
loop of variable length (usually about 40cm) that connects the descending colon to the 
rectum. The large omentum attaches the transverse colon to stomach with the gastrocolic 
ligament and hangs down covering the small bowel. The rectum (approx. 15cm long) is the 
terminal fixed part of the large intestine. The upper third is covered with peritoneum and 
below that the rectum is retroperitoneal and ends in the anal canal (4cm) at the level of 
the end of the coccyx before the anus in the perineum. In the anal canal the dentate line 
(mucocutaneus line) indicates the border where the intestinal mucosa becomes squamous 
epithelium and the skin starts, Figure 3. The arterial supply to the ileum and colon all the 
way to the splenic flexure drives from superior mesenteric artery (SMA) and its branches. 
The ileocolic artery is of specific importance because it supplies blood to the J-pouch. The 
??????????????????????????????????????????
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descending colon and rectum have blood supply from inferior mesenteric artery (IMA) and 
its branches Figure 2. The arteries that supply the colon anastomose in the marginal artery. 
(Moore et al., 2014; Hiltunen, 2018.)
??????????????????????????????????????????????????
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2.2.3 Surgical technique
2.2.3.1 Subtotal colectomy
If surgery is performed in an emergency setting or if the risks for anastomoses are otherwise 
too high, colectomy with end ileostomy is performed first and the rectum is left in situ. 
As the ascending and descending parts of the colon lie retroperitoneally, they have to 
be mobilized before dissecting the mesocolon. The transverse colon and its mesocolon are 
mobile, but attached to the large omentum. The omentum is preserved and detached from 
the transverse colon. If the surgery is not for malignant disease or if there is no high grade 
dysplasia and therefore risk of malignancy, the vessels and mesocolon can be divided near the 
bowel. The ileocolic artery should be preserved when possible for the J-pouch to have good 
circulation. A laparoscopic approach is associated with a lower postoperative complication 
rate and therefore should be preferred, also in emergency settings if the expertise needed 
is available (Öresland et al., 2015). The management of the remaining rectum following 
colectomy for acute severe colitis includes three options: 1) intra-peritoneal rectal stump 
closure, 2) creation of a mucous fistula in the rectosigmoid region 3) positioning the closed 
rectosigmoid remnant in the subcutaneous tissue in an attempt to prevent peritonitis in the 
event of a stump blowout. Rectal stump leakage resulting in pelvic sepsis occurs in 6–12% 
(Carter et al., 1991). The largest study on this matter during the laparoscopic era compared 
Hartmann’s stump and subcutaneous placement of the rectosigmoid stump. There was 
no difference between groups between overall pelvic sepsis or reoperation rates but the 
leakage rate was twofold in the subcutaneous group although statistically it did not reach 
significance. Hartmann’s procedure is easier to perform and was associated with decreased 
operating time and conversions. (Gu et al., 2013.)
2.2.3.2 Proctectomy
Most surgeons prefer to mobilize the rectum in the avascular mesorectal plane as this allows 
bloodless preparation in a clearly defined anatomical plane and because they are used to 
this technique from rectal cancer surgery. The technique of rectal dissection close to the 
rectum preserving the mesorectum may have effect on the rate of septic complications and 
the preservation of sexual function (Öresland et al., 2015). One series with 131 patients 
in which the mesorectum was preserved had fewer septic complications (1.5%) than the 
previously reported 3–15% (Rink et al., 2009). Sexual dysfunction has been reported to 
be as high as erectile dysfunction in 14% and retrograde ejaculation in 19% after RPC and 
is due to damage to pelvic nerves lying close beneath the mesorectum in the upper pelvis 
(Tiainen et al., 1999a; Hueting et al., 2004).
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2.2.3.3 Anastomosis
During the early years of IPAA surgery anastomosis was performed hand sewn (HS). The 
idea is to do a total mucosectomy and sew the ileal pouch to the dentate line. This procedure 
has the advantage of removing all the diseased or potentially diseased mucosal tissue. Later 
on, double-stapled (DS) ileoanal anastomosis has been performed 1–2cm above the dentate 
line leaving the transitional mucosa in place. Stapled anastomosis is technically easier and 
results in less tension on the mesentery and this could be important in patients with shorter 
mesenteries. (Figure 3.) 
HS anastomosis has been reported to be more frequently connected with incontinence and 
pad use, especially at night time (Reilly et al., 1997; Lovegrove et al., 2006; Kirat et al., 
2009). Preserving the rectal mucosa is important in the preservation of anal resting pressure 
(Gozzetti et al., 1994) and this is thought to explain the more frequent incontinence with 
HS technique. 
Septic pouch complications and anastomotic stricture have reportedly been more 
frequent with hand-sewn anastomoses (Ziv et al., 1996; Fukushima et al., 2000; Kirat et al., 
2009). In one meta-analysis including four prospective randomized studies no statistically 
significant differences were found in terms of functional outcome or manometric sphincter 
???????????????????????????????????????????????????????????????????????????????????????????
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continence (Schluender et al., 2006). Several large studies show that there is no difference 
in the likelihood of developing pouchitis after IPAA between HS and DS (Lovegrove et al., 
2006; Kirat et al., 2009). However, cuffitis, in which the rectal stump is inflamed, is solely a 
DS problem and the incidence has been reported to be as high as 15% (Thompson-Fawcett 
et al., 1999).
Mucosectomy is performed to eliminate the possibility of inflammatory and/or 
neoplastic changes, but mucosectomy of the anal transitional zone (ATZ) is not always 
complete (Lovegrove et al., 2006). A large study on IPAA patients showed the pooled 
prevalence of dysplasia to be the same 1.13% in the pouch and the remnant and the cases 
of malignancy are very rare in the IPAA population (Borjesson et al., 2004; Scarpa et al., 
2007). Risk factors for dysplasia of the pouch or rectal cuff include cancer or dysplasia in 
the proctocolectomy specimen, duration of UC preoperatively PSC and chronic pouchitis 
(Scarpa et al., 2007). No difference in the incidence of dysplasia in the residual rectal cuff 
has been detected (Lovegrove et al., 2006).
The European Crohn’s and Colitis Organisation (ECCO) guidelines state that DS 
should be preferred but the rectal cuff left should me no more than 2 cm in length (Öresland 
et al., 2015). The American guidelines state that both anastomotic types are acceptable but 
that it is important for IBD surgeons to master both techniques (Ross et al., 2014). 
2.2.3.4 Covering stoma
IPAA can be performed as a one-, two- or three-stage procedure. In emergency conditions, 
a total colectomy with end ileostomy will precede the pouch procedure. ECCO states 
that IPAA for ulcerative colitis should be covered with a loop ileostomy, especially in the 
presence of risk factors (Öresland et al., 2015). However, the issue about covering ileostomy 
is still under debate and practices vary between institutions. 
Pelvic sepsis can not only have immediate potential life-threatening consequences but 
is also associated with pouch dysfunction and ultimate pouch failure (Forbes et al., 2009). 
Several risk factors for pelvic sepsis have been identified, such as high body mass index 
(BMI) >30, preoperative corticosteroid medications, the operating surgeon or the final 
pathology in the specimen being CD or IC (Kiran et al., 2010).
Only one randomized controlled study has been published with 23 diverted and 22 
non-diverted patients, reporting that risk of pelvic sepsis was not increased by omitting 
diversion (Grobler et al., 1992) Some studies report that use of covering ileostomy reduces 
the morbidity of anastomosis leakage and pelvic sepsis (Tjandra et al., 1993; Williamson 
et al., 1997; Heuschen et al., 2001; Mennigen et al., 2011). Arguments against the routine 
use of a diverting ileostomy include the need for a subsequent surgical procedure, which 
entails an additional hospital admission and further re-operative morbidity (Grobler et al., 
1992; Nastro et al., 2010; van Westreenen et al., 2012; Sahami et al., 2016; Karjalainen 
et al., 2019). Other authors conclude that closure of ileostomy after three-stage IPAA 
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is associated with a low rate of serious complications (Wong et al., 2005; Rottoli et al., 
2018) and therefore routine use should be acceptable. A multicentre report reviewing the 
practice of pouch surgery in Great Britain and Ireland showed a slight decrease in the use 
of covering ileostomy: before 2013 it was 82.9% and in the period 2013–2017 it was 77.3% 
(Worley et al., 2018a).
In a recent large (n=621) retrospective multicentre study the leakage rates were quite 
high for both ileostomy and no ileostomy groups (16.7% vs. 17.1%, p=0.921). The higher 
leakage rate than previously reported was thought to be due to operating on only IBD 
patients excluding FAP patients and to the lack of a precise definition of anastomotic 
leakage. The authors found no benefit from the use of covering ileostomy but speculated 
that patients with known risk factors for leakage should be operated on with subtotal 
colectomy and end ileostomy and the IPAA should be postponed. (Sahami et al., 2016.) 
Therefore, these factors may serve to create a more selective trend based as regards the use 
of covering ileostomy (Lovegrove et al., 2011). 
Most centres plan ileostomy closure three months after RPC because earlier surgery is 
believed to be more difficult due to adhesions and therefore more dangerous (Mennigen et 
al., 2014). The largest study (n=1504) on outcome of ileostomy closure after RPC studied 
this matter and found wound infection to be significantly more frequent in early closers 
(Wong et al., 2005). The selected studies exploring the use of covering ileostomy are 
summarized in Table 3. 
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2.2.3.5 Laparoscopy and novel techniques
Laparoscopy has been shown to be safe and effective in UC surgery in several studies. The 
major advantages are reduced blood loss and faster recovery and reduction in adhesion 
development (Tilney et al., 2007; Hull et al., 2012). In addition, the long-term functional 
results have been reported to be similar to open surgery (Mineccia et al., 2018; Lavryk et 
al., 2018). In a large case-matched study, laparoscopic IPAA was associated with better 
functional results and quality of life during the first two years and after that the results 
became similar (Lavryk et al., 2018). Due to reduction in adhesion formation after 
laparoscopic approach, the infertility rate has been reported to be significantly reduced in 
young women (Bartels et al., 2012; Beyer-Berjot et al., 2013). Remzi et al. found in a large 
pouch salvage surgery study that primary laparoscopy IPAAs tended to have longer rectal 
stump than open procedures (Remzi et al., 2015) and might cause obstructive problems. 
However, these results concerned solely the pouch failure group. 
An alternative minimally invasive technique for IPAA in the approach to laparoscopic 
surgery includes the use of the da Vinci robot (Intuitive Surgical Inc., Sunnyvale, CA). 
Robot-assisted laparoscopy (RAL) provides improved 3-dimensional and high-definition 
visualization of the pelvis and multiple degrees of freedom, which greatly enhances 
performance, especially when working in narrow spaces. Robotic surgery has come to 
be used increasingly in colorectal surgery. The advantages of RAL over conventional 
laparoscopy have so far been limited to a lower conversion rate and lower intraoperative 
blood loss, as reported by two meta-analyses primarily based on data from studies on rectal 
cancer (Yang et al., 2012; Trastulli et al., 2012). The use of RAL for IPAA is still confined 
to single-centre studies with limited numbers of patients. These studies have used RAL 
for proctectomy after colectomy and then the colectomy was performed using traditional 
laparoscopy first because of the benefits afforded by robot is in the pelvic area. Two studies 
concluded that RAL is safe and feasible for proctectomy and IPAA (Pedraza et al., 2011; 
McLemore et al., 2012) one states that the short-term outcome is comparable to that of 
laparoscopy (Miller et al., 2012) and one study compared RAL to open surgery and found 
the results acceptable (Mark-Christensenal., 2016). 
The last new innovative techniques in surgery such as single incision laparoscopic 
surgery, transanal total mesorectal excision (TaTME), and natural orifice specimen 
extraction surgery have also been introduced to UC surgery. These are not in general use 
and experiences are based on small single-institution series (de Lacy et al., 2019). Moreover, 
TaTME, for example is a challenging technique with a long learning curve and if not 
properly mastered can lead to devastating complications (Atallah et al., 2017). 
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2.2.4 Surgical outcome
The main goal of IPAA surgery is for the patient to have a well-functioning pouch and 
long-lasting good quality of life. These are the most important parameters when assessing 
the operative outcome.
2.2.4.1 Early morbidity
IPAA surgery is considered major abdominal surgery and therefore a certain number of 
other than pouch-related complications are inevitable even though everything is done 
according to good surgical practice. The patients are typically young and otherwise healthy 
and operations are performed in tertiary centres so mortality is low – usually less than 1% 
(Tulchinsky et al., 2003; Fazio et al., 2013). 
Although mortality is very low the IPAA procedure has an appreciable postoperative 
morbidity of 35% (Fazio et al., 2013). Morbidity after IPAA is traditionally divided into 
early complications (< 30 days after surgery) and late complications.
 The most important complications considering the functional results are pouch-related 
complications 6–25% (de Zeeuw et al., 2012; Sagar & Pemberton, 2012). Pouch-related 
septic complications include anastomotic leakage, abscesses and fistulas (Heuschen et al., 
2002a; Shen et al., 2006). A recent long-term study from Belgium reported the overall 
leakage rate for patients operated on in 1990–2015 (n=335) to be 14.9% (Germain et al., 
2017). Different definitions of pelvic sepsis or septic complications or how a leakage is 
diagnosed sometimes makes it difficult to compare the results of different studies. Risk 
factors for pouch-related septic complications include steroid use, BMI >30, patient’s age 
older than 50 years and surgeon’s experience (Kiran et al., 2010). The risk of preoperative 
use of anti-TNFα and anti-integrin agents is unclear. 
A large review study calculated the pooled incidence from 46 studies for pelvic sepsis 
to be 7.5% (95% CI, 6.1–9.1). In this study the fistula was apart from pelvic sepsis and 
the pooled incidence was 4.5% (95% CI 3.5–5.7) (de Zeeuw et al., 2012). Because patients 
who experience early leakage or other pelvic sepsis have a higher risk of subsequent pouch 
dysfunction and failure, aggressive management is required (Heuschen et al., 2002b). 
Recently, endo-cavitational vacuum therapy (Endo-SPONGE®) with early perineal closure 
of the leak has been reported to be more effective than the previously mainly used passive 
strategy with diversion and drainage. A German study reported no difference between 
early closure treated patients and control patients without leakage in pouch function (p = 
0.647) and pouch failure rates (0/18 versus 5/133, p >0.99) were also similar. Conventional 
treatment resulted in poorer pouch function (p = 0.016) and a higher pouch failure rate 
(5/22 versus 5/107, p = 0.013) than in control patients (Wasmann et al., 2019). 
Another early pouch-related complication is haemorrhage, but this is quite uncommon 
(Fazio et al., 1995). Pouch endoscopy with clot evacuation and irrigation with adrenaline 
solution is often successful (Lian et al., 2008). 
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In addition to the morbidity caused by ileostomy closure, the early complications of 
ileostomy patients must be born in mind. Some have reported no difference in overall 
complication rates after the initial RPC (ileostomy 29.2% vs. no ileostomy 42.4%, p=0.167), 
but fewer second laparotomies for the management of complications in the ileostomy group 
(4.5% vs. 30.3%, p<0.001). (Mennigen et al., 2011.) In a recent Finnish study where covering 
ileostomy was used, patients reported having more early leakage (6.6% vs. 1.7%, P=0.04), 
SBO (22.7% vs. 7.2%, p<0.0001) and dehydration (25.2% vs. 5.9%, P<0.0001) as an early 
complication than did those without ileostomy. Readmission to hospital was also more 
frequent among ileostomy patients. (Karjalainen et al., 2019.) 
2.2.4.2 Late morbidity
The most common late complication is pouchitis, which affects 7-46% of patients depending 
on the definition (Dalal et al., 2018). It is an idiopathic inflammation in the pouch that 
leads to urgency, increased frequency of bowel movements and abdominal pain. Patients 
with coexisting PSC have been shown to have an increased incidence of pouchitis, reaching 
up to 79% ten years after IPAA (Penna et al., 1996). Pouchitis may be acute or chronic 
relapsing pouchitis. The exact aetiology is unknown, but interestingly it does not appear 
to affect pouches formed for familial adenomatous polyposis (FAP) (Barton et al., 2001). 
The most used and validated scoring system for pouchitis is the Pouchitis Disease Activity 
Index (PDAI). The index consists of stool frequency, rectal bleeding, urgency, fever and 
endoscopic and histologic findings. A total score of 7 or higher is defined as pouchitis. 
(Sandborn et al., 1994.) (Table 4.) A simpler modified pouchitis disease activity index 
(mPDAI) has also been created and has been proven to work well. This index omits the 
histology and is therefore faster and less costly (Shen et al., 2003). First-line therapy for acute 
pouchitis should be a 2-week course of metronidazole or ciprofloxacin (Shen et al., 2001). 
In the case of relapsing pouchitis evaluation of secondary reasons such as use of NSAIDs, 
Clostridium or cytomegalovirus infection, evaluation of surgical complication (leak, 
stenosis and fistula) or CD should be ruled out with tests and endoscopy. If no secondary 
cause can be found antibiotic maintenance therapy or in some cases immunosuppressive 
therapy is used. (Dalal et al., 2018.) Patients with severe chronic pouchitis should be 
reviewed together with gastroenterologists. 
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?????????????????????????????????????????
????????????????????????????????????
Criteria Score
Clinical symptoms
Stool frequency
Usual postoperative frequency
1–2 stool/ day > postoperative usual
???????????????????????????????????
0
1
2
Rectal bleeding
????????????
Present daily
0
1
Faecal urgency or abdominal cramps
????
Occasional
Usual
0
1
2
Fever????????????????????????
Absent
Present
0
1
??????????????????????
Oedema
Granularity
??????????
Loss of vascular pattern
???????????????
Ulceration
1
1
1
1
1
1
??????????????????????????????
?????????????????????????????????????????
Mild
Moderate + crypt abscess
Severe + crypt abscess
1
2
3
????????????????????????????? (mean)
< 25%
25–50%
>50%
1
2
3
The risk for small bowel obstruction (SBO) is high for IPAA patients due to combined 
abdominal and pelvic dissection, the need for multiple operations and higher risk for septic 
complications (Gorgun & Remzi, 2004). Large studies report an incidence of 13–25% 
(Fazio et al., 1995; Erkek et al., 2008). Most episodes can be treated conservatively, whereas 
about 25% require surgery (Fazio et al., 1995). One would expect the laparoscopic approach 
to entail less adhesion and therefore less SBO, yet this was not shown in a meta-analysis 
comparing laparoscopic and open pouch surgery (Singh et al., 2013). 
Anastomotic strictures are not uncommon and are seen in 14% (Fazio et al., 1995) and 
are usually related to a local complication. Studies have demonstrated that lower rates 
of stricture follow stapled anastomoses than hand-sewn anastomoses (Rossi et al., 2002; 
Prudhomme et al., 2003). If severe, the stricture may obstruct the outlet of the pouch and 
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result in evacuation problems and pouch dilation. Short and soft strictures can be gradually 
dilated with Hegar’s dilators. 
Pouch-related fistulas may be vaginal, perineal, cutaneous or presacral (Gorgun & 
Remzi, 2004). Fistula may occur in 5-10% of patients (Fazio et al., 2003; Tekkis et al., 
2005). Fistulas may develop after IPAA as a result of inflammation within the perianal 
tissues around the pouch. A large cohort study with comprehensive follow-up identified 
five independent predictors of pouch-related fistula: gender, previous anal pathology, 
final pathology especially CD, anorectal physiology and pelvis sepsis (Tekkis et al., 2005). 
Another large study reported no predictive value for gender nor type of anastomosis used 
but UC versus FAP as the initial disease type was a risk factor for developing fistula (Gecim 
et al., 2000). Management of the fistulae depends on the severity of the symptoms. Some 
minimally symptomatic fistulae may require only a seton placement, others may require 
diversion with an ileostomy and subsequent fistula repair (Ng et al., 2019). Perineal 
approaches include fistulectomy and endoanal advancements flaps and are suitable for low 
fistulas. 
Pouch-vaginal fistula is of special importance because these fistulas are a source of 
considerable morbidity and impair the patient’s quality of life. Usually late presentation of 
pouch-vaginal fistula is due to CD or erosion from the staple line (Maslekar et al., 2012). 
The reported incidence is between 3 and 17% (Lolohea et al., 2005). A systematic review 
of this matter concluded that the more common low fistulas can be treated by perineal 
approaches while high fistulas are best treated with an abdominal approach. The favourable 
perineal approaches include transvaginal repair or transanal mucosal flap repair or in case 
of stapled anastomosis advance the pouch down to the dentate line. (Maslekar et al., 2012.) 
Cuffitis is an inflammatory condition of the residual rectal cuff. This is usually related to 
the stapled anastomosis being placed in the rectum rather than at the top of the anal canal 
(Sagar & Pemberton, 2012). In a study of 217 DS IPAA patients 14.7% had symptomatic 
cuffitis (Lavery et al., 1995). Topical mesalamine has been shown to be effective in the 
treatment of cuffitis (Shen et al., 2004).
2.2.4.3 Pouch function
“Normal” pouch function is usually defined as a 24h stool frequency of four to eight 
motions per day and one nocturnal motion, and the ability to defer pouch evacuation until 
convenient and nearly perfect continence (Michelassi et al., 2003). 
The same kind of function was found in a large meta-analysis of 43 studies: mean 
defecation frequency was 5.2 per 24h with a mean night-time frequency of 1.0. Mean mild 
incontinence during the day was 17% and severe incontinence 3.7% (Hueting et al., 2005). 
A more frequent meta-analyses of 96 observational studies had very similar results: mean 
defecation frequency was 5.9 per 24h with mean night-time frequency of 1.5 with mild and 
severe daytime incontinence 14.3% and 6.1% respectively (de Zeeuw et al., 2012). 
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The reports on pouch function mainly report good and stable results (Michelassi et 
al., 2003; Wheeler et al., 2005; Tulchinsky et al., 2010) whereas others have found a slight 
deterioration in number of bowel movements and continence over time (Hahnloser et 
al., 2004; Kiely et al., 2012). Although continence deteriorated slightly, it had little or no 
influence on patient satisfaction (Delaney et al., 2003; Hahnloser et al., 2004). A Swedish 
study by Karlbom showed that age over 50 years (p<0.01), presence of extra intestinal 
manifestations (p<0.05) late complications, such as anastomotic stricture (p<0.05), 
pouchitis (p=<0.01) and anal pain (p=<0.05), were related to a less favourable outcome 
(Karlbom et al., 2000). 
2.2.4.4 Fertility and childbirth
Many of the patients in need of surgery for UC are young of reproductive age. For female 
patients’ fertility, pregnancy and mode of delivery are of crucial importance. Studies have 
shown infertility rates of UC patients to be comparable to those in general population 
(Lamah & Scott, 2002). IPAA has been associated with impaired fertility (Cornish et 
al., 2007; Tulchinsky et al., 2013). A meta-analysis showed that relative risk of infertility 
was 3.17 (95% CI: 2.41–4.81) (Waljee et al., 2006). The decrease in fertility is thought to 
be caused by tubal occlusion due to adhesions. As laparoscopic surgery is associated with 
fewer adhesions, it has yielded better results for maintaining female fertility (Bartels et al., 
2012; Beyer-Berjot et al., 2013). In a recent large study of 890 patients comparing open and 
laparoscopic IPAA postoperative infertility was increased. No difference was detected in 
postoperative fertility but patients in laparoscopic group were able to conceive dramatically 
faster (Gorgun et al., 2019). 
A Danish nationwide cohort study showed that in vitro fertilisation (IVF) is used much 
more often with UC patients after IPAA than before it. The percentage of children born 
as a result of IVF is significantly higher in UC female patients after IPAA than before it. 
(Pachler et al., 2019.) 
In pelvic surgery injury to the parasympathetic or sympathetic plexus supplying the 
pelvic organs is known to constitute a risk of causing sexual dysfunction. Dyspareunia is 
increased after IPAA, but this does not impair the overall sexual function, which may be a 
result of improved overall health (Cornish et al., 2007; Bharadwaj et al., 2014). 
There is no consensus on the optimal method of delivery for women after IPAA. 
Caesarian section is more common among females after IPAA (Lepistö et al., 2007; 
Cornish et al., 2007). Vaginal delivery entails potential risks to the anal sphincter and 
therefore to continence but no significant deterioration in pouch function has been 
reported. (Lepistö et al., 2007; Cornish et al., 2007; Bharadwaj et al., 2014.) Young women 
should be counselled preoperatively about the impact of pouch surgery on fertility and 
advised that vaginal delivery is possible but that the mode of delivery should be considered 
by the obstetrician.
37
2.2.4.5 Health-related quality of life
The concept of quality of life describes the general well-being of an individual. The World 
Health Organization has defined HRQoL as an individual’s perception of their position 
in life in the context of the culture and value systems in which they live, in relation to 
their goals, expectations, standards and concerns. It is a wide-ranging concept affected in 
a complex way by the person’s physical health, psychological state, level of independence, 
social relationships and their relationships to salient features in the environment (Camilleri-
Brennan & Steele, 1999). 
The need to evaluate HRQoL to meet the objectives of therapy to improve the 
patient’s general well-being has arisen. Survival or curing the disease alone is regarded as 
an insufficient method of disease management. Only treatment which improves HRQoL 
is regarded as an effective intervention (Sajid et al., 2008). HRQoL measurement can be 
used on a population level monitoring population health and changes therein to evaluate 
the effects of health and social policies and in allocating resources. On an individual level 
measurement evaluates the effects of therapy, describes the nature of the disease and assesses 
prognosis (Ebrahim, 1995). 
Today many quality of life instruments reflect the multidimensionality of quality of 
life. There are two basic types of instrument, disease specific and generic. Disease specific 
instruments have been developed for a certain disease or a narrow range of diseases. Generic 
instruments are intended to be applicable to a wide range of health problems (Fitzpatrick 
et al., 1992). The most important function of generic instruments is to enable comparisons 
between populations with different diseases and also comparison with general population. 
Disease-specific instruments measure HRQoL in patients who suffer from a particular 
disease. A questionnaire commonly consists of several items, which can be grouped into 
dimensions. The three main domains of HRoL are physical, social and psychological. 
(Camilleri-Brennan & Steele, 1999.) Some questionnaires afford the opportunity to 
calculate a single score. The questionnaire is usually self-administered. Several different 
questionnaires have been used in studying HRQoL in UC patients, which complicates 
the comparison of different studies (Heikens & Laarhoven, 2012b). The most used general 
instrument is the SF-36 and the disease-specific inflammatory bowel disease questionnaire 
(IBDQ) (Lichtenstein et al., 2006). 
The burden of UC on quality of life was measured with a systematic review and it 
showed that patients with active disease had poorer QoL in almost all measured aspects of 
functioning and well-being and that among those with UC in remission quality of life was 
comparable to that of healthy controls or general population samples in almost all domains 
(Yarlas et al., 2018). In the earlier years of IPAA a comparison of HRQoL for conventional 
proctocolectomy and ileostomy, Kock continent pouch and IPAA was conducted and 
revealed that quality of life was best among IPAA patients (Kohler et al., 1991). Table 5 
summarizes the main points of the selected HRQoL studies published of IPAA patients. 
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Patients considered for surgery usually suffer from active disease except for the small 
percentage operated on due to cancer or risk of cancer. Therefore HRQoL results have been 
shown to improve after IPAA and in many studies to reach the level of general population 
(Thirlby et al., 1998; Fazio et al., 1999; Heikens & Laarhoven, 2012b). Poor functional 
results are connected to poorer HRQoL, however (Carmon et al., 2003; Berndtsson et al., 
2007). Also, when comparing the HRQoL results for UC and FAP it is not surprising 
that UC patients´  level of quality of life mainly improved while that of FAP patients 
deteriorated due to having been asymptomatic preoperatively.
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2.2.4.6 Salvage surgery
For some, an end stoma can be a disaster. Perineal procedures to improve the function are 
chosen according to the cause of dysfunction, dilatation for stricture and fistula surgery 
being the most common operations. In some cases transabdominal revisional surgery may 
be an option. The procedures are often complex and difficult and very few centres gain a 
proper amount of experience due to the rarity of the procedure. 
Indications for pouch reconstruction can be divided into mechanical and infectious/
inflammatory. Identification of the precise cause of pouch dysfunction permits a surgical 
strategy to be formulated. Preservation of the original pouch is recommended if possible 
and the greatest success after redo pouch surgery is seen in patients with mechanical 
complications. (Sagar & Pemberton, 2012.) 
Proper salvage surgery studies come from big pouch centres or meta-analyses. In a large 
Cleveland clinic study (n=502) on transabdominal salvage surgery the most common reason 
for surgery was leakage/fistula 52%, a new pouch was created in 41% and was J-pouch 87% 
and HS anastomoses in 82% of the cases. The functional results and QoL were found to be 
good postoperatively (Remzi et al., 2015). 
A meta-analysis pooled the data on salvage surgery and successful healing was reported 
in procedures overall in 73.5%, in redo surgery 82.2%, revisional surgery 79.6% and in local/
perineal procedures 68.5%. Postoperative morbidity was 41.4% for the overall procedures 
and functional success was achieved in a total of 71.9%, redo surgery in 83.9%, revisional 
surgery in 75.8% and local/perineal procedures in 71%. An eventual 18% pouch excision 
rate after re-do pouch surgery was reported. (Theodoropoulos et al., 2015.) 
2.2.4.7 Pouch failure
Despite the evolved details of the operation and centralization of surgery to centres with 
the number of operations on an acceptable level, pouch-related complications and poor 
functional results may necessitate the excision of the pouch or the building of a permanent 
stoma. The long-term failure rate for IPAA is reported to be 5–17% (Sagar et al., 1996; 
Meagher et al., 1998; Lepistö et al., 2002; Tulchinsky et al., 2003; Tekkis et al., 2010). A 
large meta-analyses showed a reduction of 2.5% in the pouch failure rate in studies published 
before and after the year 2000 (de Zeeuw et al., 2012). Cumulative incidences of pouch 
failure have been reported in a Danish national study on 1992 patients reaching a 5-year 
risk of 9.1% (95% CI 7.9–10.4), a 10-year risk of 12.1% (10.7–13.7) and a 20-year risk of 18.2 
(16.1–20.4), median follow-up time being 11.4 years. (Mark-Christensen et al., 2018.) The 
biggest centre performing IPAA surgery in Finland reported a 1-year risk of 1%, 5-year risk 
of 5% and 10-year risk of 7% (Lepistö et al., 2002). The most common indications for pouch 
failure are inflammatory complications such as leakage or fistula, chronic pouchitis, CD 
and poor pouch function (Korsgen & Keighley, 1997; Tulchinsky et al., 2003; Tekkis et al., 
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2010). The frequencies, indications and possible risk or protective factors of selected failure 
studies reporting these parameters are shown in Table 7.
Many studies have examined the risk factors for pouch failure in individual patients. 
Higher age (Wibmer et al., 2010) and excessive weight gain (Wu et al., 2013) have been 
associated with an increased risk for pouch failure. Also, in a Danish national study of 
pouch failure the risk of failure was higher for women HR 1.39, 95% CI 1.10–1.75, primary 
non-diversion HR 1.63, 95% CI 1.11–2.41 and a low hospital volume HR 2.30, 95% CI 
1.26–4.20 (Mark-Christensen et al., 2018). A large study from Cleveland clinic predicted 
survival of the pouch to be worse for two-stage procedure (HR, 1.44; 95% CI 1.08–1.93), 
CD (HR, 2.37; 95% CI 1.48–3.79), hand-sewn anastomosis (HR, 1.72; 95% CI, 1.23–2.42) 
and diabetes (HR, 2.31; 95% CI, 1.25–4.24) (Manilich et al., 2012). 
There is one score, The Cleveland Clinic Foundation ileal pouch failure (IPF) score 
which was formed from the risk factors recognized in a large multivariate analysis (Fazio et 
al., 2003). These factors and the calculation of the index are presented in Table 6. 
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??????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????
Risk Factor Points
Diagnosis
???
UC on intermediate colitis
Crohn’s disease
0
1
1.5
Patient comorbidity
??????????????????????
1 comorbid condition
2 comorbid conditions
0
0.5
1.0
Prior anal pathology
???????????????????????
Prior anal pathology
0
1
Anal sphincter manometry 
????????????????
??????????????????????????????????
0
1
Anastomotic separation
?????????????????????????
Anastomotic separation
0
1
Anastomotic stricture
??????????????????????????????????????
Symptomatic stricture
0
1
Pelvic sepsis
?????????
One episode of pelvic sepsis
Two or more episodes of pelvic sepsis
0
1
2
Fistula formation
?????????
?????????????????????
????????????????????
0
1
2
TOTAL score =
Pouch failure is defined as the need for permanent ileostomy with or without a pouch 
excision operation. In previous reports the percentage of pouch excision in failure patients 
has varied: in the study by Foley 44% (Foley et al., 1995), Meagher and Tulchinsky 60% 
(Meagher et al., 1998; Tulchinsky et al., 2003), 84% in a study by McRae et al. (McRae et al., 
1997) and in a study from Finland’s biggest IBD surgery centre all 52 failed pouches were 
excised and none diverted (Lepistö et al., 2002). 
Pouch excision is a demanding procedure because of the need for reoperation deep in the 
pelvis and often after a chronic pelvic sepsis setting. In one study 57% of the pouch excision 
patients experienced short-term morbidity and 37% long-term morbidity and 11% needed 
short-term (<30d) reoperation and 13% needed long-term (>30d) reoperation (Lightner 
et al., 2017). A large multicentre study of 381 pouch excision patients reported a 30-day 
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major morbidity of 27.7% and reoperation required by 5.5% of the patients (Lachance et al., 
2018). The major cause of postoperative morbidity after pouch excision is due to surgical 
site infection, especially for perineal wound (Karoui et al., 2004; Prudhomme et al., 2006). 
Kiran et al. compared short and long-term morbidity after pouch excision and pouch left in 
situ among ileostomy patients and found no difference between the groups. Quality of life 
was found to be significantly better in the pouch excision group than in the group with the 
pouch left in situ. (Kiran et al., 2012). 
Bengtsson et al. analysed their diverted pouch failure patients who did not undergo 
excision and found no dysplasia or cancer in histopathology in pouch biopsies. None of the 
patients requested further surgery and the majority had satisfactory ileostomy function 
(Bengtsson et al., 2007). Altogether, dysplastic transformation in the ileal pouch has been 
estimated to be rare (Hulten et al., 2002; Borjesson et al., 2004).
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3 Aims of the Study
The aim of this thesis was to analyse the operative outcome of UC patients operated on 
with RPC + IPAA in Tampere University Hospital.
The detailed aims were as follows:
1. To evaluate the long-term changes in operative treatment and early and late 
complications related to IPAA.
2. To explore health-related quality of life after IPAA in those with poor or good 
pouch function and to compare that to patients with active or inactive UC and to 
general population.
3. To evaluate the long-term functional outcome after IPAA.
4. To examine the pouch failure percentage of the IPAA patients and analyse the 
reasons for pouch removal and life cycle of the pouch in this patient population. 
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4 Patients and Methods
4.1 Study populations
All patients over 18 years of age with UC who underwent RPC + IPAA at Tampere 
University Hospital in the period 1985–2016 were identified in the hospital records 
using all ICD-9 and ICD-10 codes for UC and NOMESCO Classification for Surgical 
Procedures (NCSP) codes for the operations performed. The use of wide spectrum of codes 
was in order to find all the cases. This also made it possible to exclude probably incorrectly 
recorded operation codes. A database was collected from patient files including details on 
patient history, surgical technique, postoperative morbidity, and follow-up. In Studies I, II 
and III clinical data for the period 1985–2009 and in Study IV for the period 1985–2016 
were retrieved from this registry. 
In study IV 75 patients had moved elsewhere in Finland and therefore we did not have 
reliable information on follow-up and whether they had their pouch in use or not. Data on 
possible pouch excisions on these patients were retrieved from the register in the National 
Institute for Health and Welfare (NIHW). The patients were identified by the NCSP 
procedure codes ICD-9 for the period 1985–1996 and ICD-10 from 1996 onwards. 
Study I included altogether 352 patients. In studies, II and III of these 352 patients 
282 were alive with functional pouch and could be located. In study IV we had registry 
information from a longer period and had 491 patients in the IPAA registry. The median 
follow-up time in study I was five years (range 1 month to 24 years, and in Study IV is was 
11 years (range 1 day to 33 years). Altogether 50 of the IPAA patients had had pouch failure 
and comprised the study population in study IV. 
The control group in study II comprised 408 age and gender matched UC patients from 
the local IBD registry. It is a prospective register for all adult patients with diagnosed IBD. 
The examination of the generic 15D scores used a general population sample obtained from 
the National Health 2011 Survey. 
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To study the effect of time from surgery to HRQoL (Study II) the RPC patients were 
divided into subgroups of ≤10 years, 10.1–20 years and >20 years from surgery. To study 
the effect of age at the time of surgery on functional outcome (Study III) the RPC patients 
were divided into subgroups of ≤35, 36–62, ≥63 years of age.
4.2 Methods
4.2.1 Study I
Early complications were defined as occurring within 30 days of the operation and late 
complications thereafter. SBO was considered a complication when hospital stay exceeded 
the median 10 days. Anastomotic stricture was considered a complication if it caused 
functional difficulties and dilation was needed. Four groups of BMI were created (<22, 
22–24, >24–27, and >27) to examine the effect of BMI. Indications were regarded as 1) 
acute colitis in need of emergency colectomy, 2) chronic colitis with inadequate response 
to medical treatment and 3) cancer of risk of cancer, typically dysplasia or pseudopolyposis. 
?????? ???????????????????????????????????
The questionnaires were sent by post and one reminder was sent to non-respondents. 
Two different instruments were used to measure HRQoL; the generic (15D) 15-item 
questionnaire and one disease-specific 32-item IBDQ, which addresses four different 
aspects of life: digestive symptoms, social functioning, emotional status and systemic 
symptoms. Total IBDQ score ranges from 32 to 224, a higher score indicating better quality 
of life. The IBDQ was used under licence from McMaster University, Hamilton, Canada. 
Pouch function was assessed by Öresland score with the permission of the developer. The 
questionnaire includes items on day-time and night-time bowel movements, incontinence, 
pad usage, urgency, diet, medication and social handicap. The ratings are summarized 
into a single score (range 0–15; 15 being the worst possible). UC disease activity in the 
control group was examined by simple clinical colitis activity index (SCCAI). The 15D is a 
Finnish questionnaire and the rest of the questionnaires were translated from English and 
backtranslated to confirm linguistic accuracy. The Finnish versions of the 15D, SCCAI 
and Öresland score are to be found in the appendix. The IBDQ cannot be published due 
to licence agreement.
Of the study population of 352 IPAA patients 282 were eligible for inclusion in this 
study as their pouch was in place and they were alive and accessible. Altogether 187 
(66.3%) returned the questionnaires; 87 (67%, of the women and 100, 66% of the men). 
Characteristics of the respondents are presented in Table 8. The 95 patients who did not 
respond had the same gender distribution, but they were on average three and a half years 
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younger. There were no differences in the most important complications concerning pouch 
function; leakage or pelvic sepsis. 
In this questionnaire study non-operated UC patients were used as control group. Of 
the 408 UC patients 153 (37.5%) returned the questionnaires; 71 (46%) women and 82 
(54%) men. The basic characteristics of these patients are presented in Table 8.
????????????????????????????????????????????????????????????????????????????????????
Number of 
patients
Female
?????
???????????????
?????? ??????
(range)
Time from surgery 
????????????????????
median (range)
IPAA patients ??? ??????? ?????????? ?????????
UC patients 153 71 (46) ?????????? ?????????
?????? ????????
The Charlson Comorbidity Index (CCI) was used to categorize pouch failure patients 
comorbidities. BMI was considered high at >30kg/m2. Clavien-Dindo (C-D) classification 
was applied to classify complications. CD was diagnosed in endoscopy, histology, clinical 
picture and capsule imaging or MRI (magnetic resonance imaging) when necessary. Early 
complications were again defined as occurring within 30 days of the operation. 
4.2.4 Statistics
Statistical analysis was performed with IBM SPSS Statistics 25.0. For categorical variables, 
the results are given as frequencies and percentages, for continuous variables as means and 
standard deviations, or as medians with range. Chi-Square or Fisher’s exact test was used to 
assess differences in categorical variables. In studies I, III and IV binary logistic regression 
analysis was used to identify independent risk factors related to leakage, functional results 
and pouch failure. Results are shown as odds ratios (ORs) with their 95% confidence 
intervals (CIs). Statistical significance was set at p≤0.05. In Study II the power calculations 
were made using PS Power and Sample Size Calculations program, the difference for 15D 
being 0.03, power 80% and statistical difference 0.05. 
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4.2.5 Ethical aspects
All studies were carried out in accordance with the Helsinki Declaration and the 
guidelines for good clinical practice. Studies I and IV were retrospective and observational 
and therefore, no ethical approval of the committee was required. The medical director of 
the study hospital granted approval. The Ethics committee of Pirkanmaa Hospital District 
(code R12100) approved protocol for Studies II and III. All participants gave written 
consent to participate. In Study IV data on the pouch excision of the patients who had 
moved away from Pirkanmaa were retrieved from the register of the NIHW, with their 
permission THL/1965/5.05.00/2018. 
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5 Results
5.1 Surgery (I)
The IPAA patient baseline characteristics are presented in Table 9. The patients were 
young and healthy with minor co-morbidities and predominantly normal BMI. The 
characteristics have not changed from those of the population in studies I (1985–2009) and 
IV (1985–2016).
??????????????????????????????????????????????????????????????????????????
Sex n ?? median range
men ??? 57
women ??? 43
Age at time of surgery ?? ?????
BMI at surgery 24 16–42
Co-morbidity index
0
1
2
3
443
35
11
2
Duration of disease before surgery (yrs.) 5 0–45
Indication for surgery
Acute 
Chronic
????????????????????????
213
246
32
43
??
6.5
Hospital stay (d) ? ??????
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The first IPAAs were all HS anastomoses, but around the year 2005 the practice in our 
hospital changed to the routine use of stapled anastomoses as can be seen in Figure 4. Today 
hand-sewn anastomoses are performed only in cases where rectal dysplasia is observed 
preoperatively.
The very first operations were performed with covering ileostomy and after that there was a 
quite long period when covering ileostomy was not routinely used, and was performed only 
when considered necessary. Figure 5 shows how the use of covering ileostomy has changed 
in our hospital. From approximately 2005 onwards, covering ileostomy has been used as a 
routine procedure.
??????????????????????????????????????????????????
?????????????????????????????????????????????
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5.2 Morbidity (I)
5.2.1 Early morbidity
One patient died the next day after IPAA giving a mortality rate of 0.3%. The most important 
early pouch related complications are listed in Figure 6. Eighty-one (23%) patients were 
readmitted in the early postoperative phase. Reasons for readmission to hospital in the 
early postoperative phase are presented in Figure 7. Thirty-two (9.1%) patients required 
re-operation in the early postoperative phase because of complications. Reasons for re-
operations were leakage in 25, haemorrhage in two, SBO in four and perforation in one. 
Omission of covering stoma and high BMI were independent risk factors for leakage; ORs 
of 3.68 (95% CI 1.61–8.42) and 1.11 (CI 1.01–1.21) respectively. There were significantly 
more leakages and early re-operations when covering ileostomy was not performed than 
when it was done, 16.4% vs. 6.0% (p=0.004) and 11.9% vs. 4.5% (p=0.02) respectively, see 
original article I Figure 1. Dehydration was the only early complication occurring more 
frequently in patients with covering stoma 6.8% vs. 0.0%, p=0.017. Morbidity related to 
closure of the ileostomies is presented in Table 10. 
Table 10. Morbidity related to closure of covering ileostomies
n or median ??????????
Overall morbidity 42 31.6
SBO 25 ????
Leakage 4 3.0
Hospital stay 7 3–46
????????????????????????????????????????????????????????????????????????????????
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?????? ?????????? ????????
The long-term complications are presented in Figure 8; pouchitis 134 (39.3%) being the 
most common. The median follow-up time was five years (range: 1month–24 years). 
????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????
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???? ???????????????????????????????????
IPAA patients scored significantly lower on eight of the 15 dimensions compared to age 
and gender matched general population, Figure 9. When the IPAA patients with good 
pouch function were compared to general population the only significantly lower score was 
seen on the excretion dimension.
HRQoL measured by the disease specific IBDQ questionnaire showed that IPAA patients 
with good pouch function had scores similar to those of UC patients in remission or 
mild disease activity. Those with poor pouch function had IBDQ scores similar to those 
with active disease Figure 10. No difference was seen in HRQoL after surgery comparing 
different indications or time from operation. The scores were lower for RPC patients with 
any indication for surgery or time from operation than for UC patients in remission but 
higher than for UC patients with active disease. The main finding of the subscores of the 
IBDQ was that patients with good pouch function showed better results on all subscores 
(bowel disorder, emotional disorder, systemic symptoms and social function) than did 
those with active colitis (p < 0.001), see Table 2 in original Study II. 
????????????????????????????????????????????????????????????????????????????
to general population n=4762
???????????????????????
57
5.4 Pouch function (III)
The majority of 131 (70%) of the patients reported having good pouch function (Öresland 
score <8). The median functional Öresland score was 5.0 for females and 5.5 for males.
More than half (55%) had daytime defecation frequency ≤5 and night time frequency 0 
or ≤1/week. Dietary restrictions were experienced by 49%, use of antidiarrheal medication 
was reported by 29% and a social handicap was experienced by 25%. When the postoperative 
results after IPAA between well-functioning pouches and poor functioning pouches were 
compared no significant difference of leakage or pelvic sepsis was recorded nor fistula, 
abscess or stricture. However, anastomotic stricture was twice as common in poorly 
functioning pouches as in well-functioning pouches, 7.9% vs. 13.2%, (p=0.199). Time 
elapsing since IPAA had no effect on pouch function. Seepage was experienced by 20% in 
daytime and by 42% occasionally at night time. Daytime seepage and use of protective pads 
were more common among older patients aged ≥63 years. Men suffered more from night-
time incontinence than did women, 51% and 33% respectively, p=0.015, this being the only 
difference found between sexes.
???????????????????????????????????????????????????????????????????????????????
???????????????????????
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A multiple logistic regression analysis of nine variables (sex, age at time of surgery, body 
mass index at time of surgery, type of anastomosis, use of covering stoma, complications 
including leakage, fistula or abscess, stricture and pouchitis) showed that only age at the 
time of surgery OR 1.03 (95% CI 1.00–1.06) p=0.07 and the development of pouchitis OR 
4.21 (95% CI 1.94–9.10) p<0.001 were independently related to a poor functional outcome. 
???? ??????????????????
Altogether 53 (10.8%) pouch failures were recorded: 10 (4.7%) out of 209 women and 43 
(15.2%) out of 282 men OR 3.58 (95% CI 1.75–7.37). The characteristics of patients and 
IPAA surgery of the pouch failure patients and patients still with pouch are presented in 
Table 11. Half of the pouch failures occurred within the first five years and 70% within 
seven years of IPAA surgery. The cumulative risk for pouch excision at five years was 5.6%, 
at 10 years 9.4% and at 20 years 15.5%.
?????????????????????????????????????????????????????????????????????????????????????????????
cohorts
(Helavirta et al. submitted)
Pouch failure
n=53
Pouch in place
?????
p-value
n or median % or range n or median % or range
Men 43 ?? ??? 55 0.000
????????? ??????????? ?????
(SD) 25 (4.7) 25 (3.4)
Age at time of IPAA (yrs.) 
median (range) 36 ??????? 37 ???????
Anastomoses 
?????????
Stapled
Covering stoma
45
?
??
??
15
36
243
???
250
56
45
57
0.000
0.003
?????????????????????? ??????
(range) ? (4–42) 11 ??????
The reasons for pouch failure were multiple. The different reasons recorded are shown in 
Figure 11. Several reasons were often recorded for a single patient. Poor function was most 
often recorded as a reason, but there was usually some septic event such as leakage, fistula 
and pouchitis or CD leading to poor function. 
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Twenty-eight (52.8%) had undergone surgery prior to pouch excision in order to maintain 
the pouch. The salvage operations were anastomotic dilatation 12 (22.6%), loop- or end 
ileostomy 14 (26.4%), fistula operation 6 (11.3%), abscess drainage 3 (5.7%), anastomotic 
repair 2 (3.8%) and new anastomosis in 1 (1.9%). The one new HS anastomosis performed 
was done transabdominally due to pouchvaginal fistula and was HS in the primary IPAA 
operation. 
Altogether 15 CD diagnoses were made in the IPAA cohort after the initial diagnosis 
of UC in five of these the diagnosis was set after pouch failure; pouch failure occurred in 
seven (47%). 
More early leakage 15 (28.3%) vs. 32 (7.3%) p<0.001, and early relaparotomy after IPAA 
11 (20.8%) vs. 31 (7.1%) p=0.003 occurred in failure patients than in those with functioning 
pouch. The only parameters significant in the multivariate analyses were leakage OR 3.65 
(95% CI 1.21–1.83) p=0.022 and male gender OR 3.83 (95% CI 1.80–8.12) p≤0.001. 
?????????????????????????????????????????????????????????????
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6 Discussion
6.1 Controversial issues of technical details in IPAA surgery
The IPAA operation has evolved in the decades during which it has been used. One of 
the main changes has been the shift from HS to DS anastomosis. When deciding which 
anastomosis to employ one must consider three aspects: first the surgical outcomes regarding 
pouch complications or pouch failure, secondly the functional result and HRQoL, and the 
risk of malignancy in the mucosa left in place for DS. 
It is still debatable whether to use a covering ileostomy or not. The most important 
consideration is the effect of the stoma in preventing septic complications and the morbidity 
connected to stoma closure.
6.1.1 Anastomosis
In the patient cohort of this study HS was mainly used during the earlier years 1985–2005 
and DS thereafter. In study I no differences were found in early pouch related complications 
for the type of anastomoses used. Among late complications anastomotic stricture was 
significantly more common for HS than DS, 17.6% and 0%, respectively. Study III showed 
that there was no difference in the type of anastomosis used in the long-term functional 
results as studied using the Öresland score. For pouch failure a difference was seen in 
univariate analysis which disappeared when the use of covering stoma and time elapsing 
since IPAA operation was taken into account. The present results that DS is preferable to 
HS are corroborated in the literature. A large meta-analysis (n=4,183 patients) concluded 
that patients with HS had more night-time incontinence (Lovegrove et al., 2006). In a 
prospective study (n=3109) postoperative septic complications, anastomotic stricture, 
SBO and pouch failure occurred more frequently in HS and incontinence was also more 
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common in HS (Kirat et al., 2009). By contrast, a meta-analysis by (Schluender et al., 2006) 
found no difference regarding the type of anastomoses used for functional results but the 
number of subjects was relatively small (n=86 vs. 98).
In the present study, the malignancy rate after IPAA was 0.4%, comprising two patients, 
both with HS anastomoses. For comparison, in a large review aiming to identify the risk 
of neoplasia after RPC the pooled prevalence of confirmed dysplasia in the pouch, ATZ or 
rectal cuff was 1.13% (range 0–18.75). The prevalence of high-grade dysplasia was likewise 
equally frequent for these anatomical parts (Scarpa et al., 2007). It has been shown that 
mucosectomy is not always complete (O’Connell et al., 1988; Lovegrove et al., 2006; Vento 
et al., 2011). DS is technically easier to perform and evidence suggests that it achieves better 
functional results and the risk of dysplasia or malignancy is low. Dysplasia or invasive 
cancer diagnosed before RPC or found in the operation specimen have been reported to be 
a signiﬁcant risk factor for the further development of neoplastic change in the pouch or 
in the rectal cuff and ATZ (Scarpa et al., 2007). In HS it is possible to remove all the rectal 
mucosa. We thus agree with the ECCO guideline and perform HS only when dysplasia is 
found in the rectum preoperatively (Öresland et al., 2015). 
6.1.2 Covering ileostomy
Study I showed that there were significantly fewer leakages and early reoperations when 
covering ileostomy was used than when it was not used (6.0% vs. 16.4%, p=0.004 and 4.5% 
vs. 11.9%, p=0.02 respectively). The morbidity connected to ileostomy closure was quite 
common, 31.6% (n=42). The most common complication was SBO (16.8%), which kept 
the patients in hospital longer. The most serious complication was leakage, which was 
luckily uncommon, occurring in 3.0%. All four patients needed early reoperation. The only 
randomized controlled study reported that risk of pelvic sepsis was not increased by omitting 
ileostomy (Grobler et al., 1992). Other studies are observational in nature and may suffer 
from selection. Some authors have concluded that use of covering ileostomy reduces the 
morbidity of anastomotic leakage and pelvic sepsis (Tjandra et al., 1993; Williamson et al., 
1997; Mennigen et al., 2011). By contrast, some state that the one-stage procedure is superior 
(Heuschen et al., 2001; Sahami et al., 2016) while others conclude that ileostomy can be 
omitted for selected patients (Widmar et al., 2019). The studies suggesting the selective 
use of ileostomy are more recent and there seems to be a trend towards this (Lovegrove, et 
al., 2011; Worley et al., 2018a). It is somewhat controversial whether ileostomy closure is 
associated with considerable morbidity (Wong et al., 2005; Mennigen et al., 2014; Rottoli 
et al., 2018; Karjalainen et al., 2019). The findings of this study support the use of ileostomy, 
accepting the increased though slight morbidity.
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6.2 Complications
Complications after IPAA can be categorized by timing and aetiology. Usually early (<30d 
after operation) and late complications are reported. Infectious complications include 
pelvic sepsis and anastomotic leakage resulting in abscess and fistulae. Inflammatory 
complications include pouchitis and cuffitis. Mechanical complications consist of 
obstruction and pouch dysfunction in various forms: stricture, pouch prolapse, low volume 
pouch or pouch volvulus (Leinicke, 2019). 
6.2.1 Early complications
The mortality in the present study included only one patient and this was because the patient 
declined blood transfusions, had a serious bleeding complication and the reoperation the 
next day could not save his life. According to the literature mortality is also low, less than 
1% (Gorgun & Remzi, 2004). One obvious reason is that the patients are mainly young and 
have few, if any, comorbidities. Thus, this and other studies indicate that the operation is 
safe in this respect. 
The most important early complications are pouch related and of these leakage or pelvic 
sepsis occur in 6–15% of patients (de Zeeuw et al., 2012; Sagar & Pemberton, 2012). In the 
present study the leakage rate was comparable, 12.5%. The leakage did not seem to have a 
negative effect on the functional results comparing poorly and well- functioning pouches 
(study III) but the pouch failure group had significantly more early leakages than did those 
with pouch in place (study IV). Infection complications were also among the main reasons 
for early reoperations (81%) and readmissions to hospital (65%) (study I). 
It is wise always to suspect leakage and then one is able to diagnose and start treatment 
promptly, which may save effects on long-term function. Traditionally the treatment 
has been diversion and drainage but new data show that better results may be achieved 
with endosponge assisted early closure (Wasmann et al., 2019). In preventing leakage the 
technical accuracy of performing anastomoses with good blood supply, without tension is 
of the utmost importance. It is important to recognise the patient-associated risk factors 
(high corticoid dosage or other preoperative medications, high BMI, aging) and to plan the 
surgery accordingly: timing of surgery and whether to perform two- or three-stage surgery. 
6.2.2 Late complications
In the present study, the most common late complication was pouchitis, occurring in 39%. 
By comparison, in the literature percentages of up to 46% have been reported (Dalal et al., 
2018). Antibiotic treatment with metronidazole or ciprofloxacin is the first-line therapy 
and the majority of patients respond to it (Shen et al., 2001). 
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IPAA patients are at high risk of SBO because of extensive abdominal and pelvic 
dissection and the possible need for several operations. In study I early SBO was recorded 
for 5.6% and late SBO with a median follow-up time of five years occurred in 13.2% of 
patients and 20% of early and 37.8% of late SBOs required surgery. The use of covering 
ileostomy did not result in more SBOs altogether 14.6% vs. 12.4%, p=0.6. A large study 
reported late SBOs in 25.3%, of which 27.6% needed surgery (Fazio et al., 1995) and similar 
results have also been reported from Sweden: 3.2% early and 25.5% late SBOs, of which 
34% needed surgery (Åberg et al., 2007). In another large study (n=1,178), the cumulative 
percentage of SBOs was 9% at 30 days, 18% at on year, 27% at five years and 31% at ten 
years. SBO was managed conservatively in the majority of cases, as operative treatment was 
required in 1% within 30 days, in 3% at one year, in 7% at five years, and 8% at ten years 
(MacLean et al., 2002). Laparoscopy has been shown to result in fewer adhesions and also 
in fewer SBOs (Hull et al., 2012). We plan to explore this in our series in the future. 
There were significantly more strictures for HS than DS in study I, 14.6% vs. 0%, p=0.001. 
Comparable percentages have been reported earlier: 12% vs. 4%, p=0.003 (Prudhomme 
et al., 2003). Stricture leading to functional problems and multiple dilatations or other 
surgical interventions and pouch failure was not rare, 23% in Study IV, which again speaks 
for the use of DS anastomoses. 
6.2.3 Pouch failure
Pouch failure is defined as new permanent ileostomy with or without pouch excision. In 
study IV pouch failure occurred in 53 (10.8%) out of 491 IPAA patients. The cumulative 
risk for pouch excision at five years was 5.6%, and threefold at 20 years, 15.5%. The long-
term failure rate for RPC has been variable, 5.8–17% in the literature (Lepistö et al., 2002; 
Tulchinsky et al., 2003; Wasmuth et al., 2010; Mark-Christensen et al., 2018). The main 
reasons for pouch failure were poor function 30%, incontinence 23%, fistula 23%, stricture 
23%, chronic pouchitis 21%, leakage 15% and CD 13%. The same reasons appear in several 
studies with long-term follow up (Lepistö et al., 2002; Tulchinsky et al., 2003; Tekkis et 
al., 2010). Many IPAA studies have included FAP patients. In a meta-analysis (n=9,317) 
the indications for IPAA were UC 87.5%, IC 2%, FAP 8.9%, CD 0.8% and other 0.7%. 
The complication and pouch failure rates were reportedly lower for FAP. (Hueting et al., 
2005.) The present study focused on UC surgery only and this should be considered when 
comparing the results of the studies. 
In the present study 15.2% of men and 4.7% of women suffered from pouch failure. 
By contrast, in a Danish population based study with 295 failures, there was a higher 
risk for female patients to experience pouch failure, HR 1.39, 95% CI 1.10–1.75 (Mark-
Christensen et al., 2018). No significant gender difference has been reported earlier (Fazio 
et al., 2003; Manilich et al., 2012; Worley et al., 2018b). The results are thus variable and 
maybe dependent on patient series. 
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Regarding whether the failed pouch should be excised or left in situ, the comparison 
of morbidity and risk of malignancy should be considered. In study IV one mucinous 
cancer was found in the operation specimen giving a malignancy rate of 0.2%. Thus, this 
seems not to be a significant problem. An early complication was recorded in 23 (44%) of 
the patients after surgery but 16 (70%) of these were C–D grade I–II and the CCI was 
grade 0 for 89% of the patients. The most common early complications were SBO in 17% 
and perineal wound infection in 6%. Readmission to hospital was recorded for 13 (25%) 
of the pouch excision patients. A limited number of studies exploring the postoperative 
complications of pouch excision link the operation to significant morbidity. The studies on 
this subject report 25–57% short-term morbidity and 5.5–19% of short-term reoperation, 
long-term complication rates of 28–40% and readmission rates of 19–38% (Karoui et al., 
2004; Lightner et al., 2017; Lachance et al., 2018). The most important and most common 
complications and reason for readmission is surgical site infection at the perineal wound 
(Karoui et al., 2004; Prudhomme et al., 2006). Interestingly, the morbidity does not differ 
when pouch excision and pouch left in situ are compared. Moreover, quality of life was 
found to be better for excision patients (Kiran et al., 2012). In the present study in all 
but one pouch failure patient pouch excision was performed. The indication for failure is 
commonly a septic event leading to incontinence, and although a diversion is performed, 
the morbidity of the incontinent pouch or fistula still persists. The patients with pouch 
excision had usually few comorbidities and the complications were mostly mild. Therefore, 
excision has been the main choice in our unit. 
???? ?????????????????????????????????????????????????????
There are two things that relate to the achievement of a good quality of life for IPAA 
patients operated on for UC: the removal of the disease symptoms and of fear of 
malignancy and the avoidance of a permanent stoma. In study II HRQoL among patients 
with well-functioning pouch was similar to that of general population and to that of non-
operated UC patients in remission. Patients with well-functioning pouches also showed 
better results in all sub scores (bowel disorder, emotional disorder, systemic symptoms and 
social function) of IBDQ than those with active colitis. This observation verifies findings 
reported earlier where pouch function was connected to level of HRQoL (Carmon et 
al., 2003; Scarpa et al., 2004; Berndtsson et al., 2007; Kiely et al., 2012), IPAA improves 
HRQoL in symptomatic UC patients (Thirlby et al., 1998; Fazio et al., 1999; Muir et al., 
2001; Polle et al., 2007; Heikens et al., 2012a) and HRQoL reaches the level of general 
population or slightly under (Thirlby et al., 1998; Richards et al., 2001; Robb et al., 2002; 
Carmon et al., 2003; Berndtsson et al., 2007; Andersson et al., 2011; Heikens et al., 2012a). 
In the present study there was no difference between groups divided by indications for 
surgery. When we operate with an indication of dysplasia on a patient whose UC is in 
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remission we can expect HRQoL to deteriorate, as was also seen in this study. For these 
patients the removal of risk of malignancy plays a bigger role. 
In study III the pouch function results for a long median follow-up of 13 years (range 
4–28) were good and stable among the majority of patients at 70% (Öresland score <8). 
The number of daily bowel movements was ≤5 in 55% of patients. These are close to what is 
considered good and “normal” frequency (4–8 day, 1 night) and almost perfect continence 
(Michelassi et al., 2003). Eighty per cent were continent during the day and 64% at night. 
Similar continence result have been reported by others (Berndtsson et al., 2007; de Buck van 
Overstraeten et al., 2014). In the present study men suffered from nocturnal incontinence 
more than women, 51% and 33% respectively, p=0.015. This finding has also been observed 
by others (Meagher et al., 1998; Farouk et al., 2000; Berndtsson et al., 2007) the reason for 
this difference remains unknown. Even if the majority experienced good functional results, 
dietary restrictions were experienced by 49% and use of bowel regulating medications was 
reported by 29%. A study from Belgium reported 50% using antidiarrheals and about half 
reporting dietary restrictions (de Buck van Overstraeten et al., 2014). 
In the present study the poorly functioning group had significantly more pouchitis 
than the well-functioning group, 51.0% and 25.6 (p=0.001). Stricture was almost twice as 
common in the poorly functioning group as among those with well-functioning pouches, 
13.2%, vs. 7.9% but the difference was not statistically significant, p=0.27. Patient’s ≥63 
years of age reported more daytime incontinence than younger ones. Other studies have 
similarly concluded that continence deteriorates in the oldest age groups, but still has a 
minor influence on patient satisfaction (Delaney et al., 2003; Hahnloser et al., 2004). Pelvic 
sepsis or leakage showed no association with poor function in this study although there 
was a clear difference for the pouch failure vs. the pouch in place groups 15 (28.3%) vs. 
32 (7.3%) p<0.001, 15 (28.3%) vs. 60 (13.7%) p=0.005 respectively. We did not explore the 
salvage operations more closely for patients with pouch still in use but 52.8% of pouch 
failure patients had had some kind of salvage operations performed before pouch excision. 
RPC with IPAA may be connected to different kinds of morbidity, and 10% failed 
in the long run. Nevertheless, most IPAA patients are doing well, and HRQoL does 
not differ from that in the population. The present findings help to inform patients of 
the IPAA operation when indication for surgery emerges. It should still be noted that 
the complication risks increase with age. Pouch malignancy seemed not to be a major 
problem. The centralization of IPAA surgery concerns not only the surgery itself but also 
co-operation with gastroenterologists, prompt diagnosis and treatment of postoperative 
complications and the knowledge to deal with different kinds of late onset pouch problems. 
The team must constantly evaluate their results and keep up to date with new treatment 
strategies. Using these guidelines we can offer the majority of surgically treated patients the 
lowest possible morbidity and high quality of life that lasts. 
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6.4 Limitations of the study
The limitations of this thesis were the retrospective nature (studies I and IV) and lack of 
annual follow-up data. The long time period and the changed routines in patient care may 
to some extent challenge the comparisons. The limitations of studies II and III were the 
large number of patients who did not return the questionnaires. In the analysis of the non-
respondent groups of patients there were no obvious major differences between responders 
and non-responders. 
???? ????????????????
In the future we are planning to explore the effect of the laparoscopic surgery initiated 
as a standard procedure from 2017 onwards. The use of biological medication and its 
effects on surgical outcome is planned to be explored. We also intend to analyse the new 
reservoirescopy follow-up protocol in use. The new robot surgery should also be explored 
prospectively.
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7 Conclusions
The main conclusions of the present thesis are:
1 Our surgical technique is justified. The data show that the most severe and important 
complications concerning pouch function remained on an acceptable level.  
2 IPAA patients with a well-functioning pouch had HRQoL similar to that in general 
population and in UC patients with their disease in remission or mildly active. 
3 The long-term functional outcome of IPAA patients was good in the majority (70%) 
of cases. Elderly patients need careful patient selection and consultation. 
4 Pouch failure occurred in 10.8% patients. The cumulative risk for pouch excision at 
five years was 5.6%, at ten years 9.4% and at 20 years 15.5%. Prevention, diagnostics 
and early aggressive treatment of septic events are of great importance, because they 
lead to deterioration of pouch function and failure in most cases. 
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10 Appendices
?????????????????????????????????????????????????????
Ohje: Lukekaa ensin läpi huolellisesti kunkin kysymyksen kaikki vastausvaihtoehdot. Merkit-
kää sitten rasti (x) sen vaihtoehdon kohdalle, joka parhaiten kuvaa nykyistä terveydentilaanne. 
Menetelkää näin kaikkien kysymysten 1–15 kohdalla. Kustakin kysymyksestä rastitetaan siis 
yksi vaihtoehto.
KYSYMYS 1. Liikuntakyky
1 (  ) Pystyn kävelemään normaalisti (vaikeuksitta) sisällä, ulkona ja portaissa.
2 (  ) Pystyn kävelemään vaikeuksitta sisällä, mutta ulkona ja/tai portaissa on pieniä vai-
keuksia.
3 (  ) Pystyn kävelemään ilman apua sisällä (apuvälinein tai ilman), mutta ulkona ja/tai por-
taissa melkoisin vaikeuksin tai toisen avustamana.
4 (  ) Pystyn kävelemään sisälläkin vain toisen avustamana.
5 (  ) Olen täysin liikuntakyvytön ja vuoteenoma.
KYSYMYS 2. Näkö
1 (  ) Näen normaalisti eli näen lukea lehteä ja TV:n tekstejä vaikeuksitta (silmälaseilla tai 
ilman).
2 (  ) Näen lukea lehteä ja/tai TV:n tekstejä pienin vaikeuksin (silmälaseilla tai ilman).
3 (  ) Näen lukea lehteä ja/tai TV:n tekstejä huomattavin vaikeuksin (silmälaseilla tai il-
man).
4 (  ) En näe lukea lehteä enkä TV:n tekstejä ilman silmälaseja tai niiden kanssa, mutta näen 
kulkea ilman opasta.
5 (  ) En näe kulkea oppaatta eli olen lähes tai täysin sokea.
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KYSYMYS 3. Kuulo
1 (  ) Kuulen normaalisti eli kuulen hyvin normaalia puheääntä (kuulokojeella tai ilman).
2 (  ) Kuulen normaalia puheääntä pienin vaikeuksin.
3 (  ) Minun on melko vaikea kuulla normaalia puheääntä, keskustelussa on käytettävä nor-
maalia kovempaa puheääntä.
4 (  ) Kuulen kovaakin puheääntä heikosti; olen melkein kuuro.
5 (  ) Olen täysin kuuro.
KYSYMYS 4. Hengitys
1 (  ) Pystyn hengittämään normaalisti eli minulla ei ole hengenahdistusta eikä muita hen-
gitysvaikeuksia.
2 (  ) Minulla on hengenahdistusta raskaassa työssä tai urheillessa, reippaassa kävelyssä tasa-
maalla tai lievässä ylämäessä.
3 (  ) Minulla on hengenahdistusta, kun kävelen tasamaalla samaa vauhtia kuin muut ikäi-
seni.
4 (  ) Minulla on hengenahdistusta pienenkin rasituksen jälkeen, esim. peseytyessä tai pu-
keutuessa.
5 (  ) Minulla on hengenahdistusta lähes koko ajan, myös levossa.
KYSYMYS 5. Nukkuminen
1 (  ) Nukun normaalisti eli minulla ei ole mitään ongelmia unen suhteen.
2 (  ) Minulla on lieviä uniongelmia, esim. nukahtamisvaikeuksia tai satunnaista yöheräi-
lyä.
3 (  ) Minulla on melkoisia uniongelmia, esim. nukun levottomasti tai uni ei tunnu riittä-
vältä.
4 (  ) Minulla on suuria uniongelmia, esim. joudun käyttämään usein tai säännöllisesti uni-
lääkettä, herään säännöllisesti yöllä ja/tai aamuisin liian varhain.
5 (  ) Kärsin vaikeasta unettomuudesta, esim. unilääkkeiden runsaasta käytöstä huolimatta 
nukkuminen on lähes mahdotonta, valvon suurimman osan yöstä.
KYSYMYS 6. Syöminen
1 (  ) Pystyn syömään normaalisti eli itse ilman mitään vaikeuksia.
2 (  ) Pystyn syömään itse pienin vaikeuksin (esim. hitaasti, kömpelösti, vavisten tai erityi-
sapuneuvoin).
3 (  ) Tarvitsen  hieman toisen apua syömisessä.
4 (  ) En pysty syömään itse lainkaan, vaan minua pitää syöttää.
5 (  ) En pysty syömään itse lainkaan, vaan minulle pitää antaa ravintoa letkun avulla tai 
suonensisäisesti.
KYSYMYS 7. Puhuminen
1 (  ) Pystyn puhumaan normaalisti eli selvästi, kuuluvasti ja sujuvasti.
2 §(  ) Puhuminen tuottaa minulle pieniä vaikeuksia, esim. sanoja on etsittävä tai ääni ei ole 
riittävän kuuluva tai se vaihtaa korkeutta.
3 (  ) Pystyn puhumaan ymmärrettävästi, mutta katkonaisesti, ääni vavisten, sammaltaen 
tai änkyttäen.
4 (  ) Muilla on vaikeuksia ymmärtää puhettani.
5 (  ) Pystyn ilmaisemaan itseäni vain elein.
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KYSYMYS 8. Eritystoiminta
1 (  ) Virtsarakkoni ja suolistoni toimivat normaalisti ja ongelmitta.
2 (  ) Virtsarakkoni ja/tai suolistoni toiminnassa on lieviä ongelmia, esim. minulla on virt-
saamisvaikeuksia tai kova tai löysä vatsa
3 (  ) Virtsarakkoni ja/tai suolistoni toiminnassa on melkoisia ongelmia, esim. minulla on 
satunnaisia virtsanpidätysvaikeuksia tai vaikea ummetus tai ripuli.
4 (  ) Virtsarakkoni ja/tai suolistoni toiminnassa on suuria ongelmia, esim. minulla on 
säännöllisesti  ”vahinkoja” tai peräruiskeiden tai katetroinnin tarvetta.
5 (  ) En hallitse lainkaan virtsaamista ja/tai ulostamista.
KYSYMYS 9. Tavanomaiset toiminnot
1 (  ) Pystyn suoriutumaan normaalisti tavanomaisista toiminnoista (esim. ansiotyö, opis-
kelu, kotityö, vapaa-ajan toiminnot).
2 (  ) Pystyn suoriutumaan tavanomaisista toiminnoista hieman alentuneella teholla tai 
pienin vaikeuksin.
3 (  ) Pystyn suoriutumaan tavanomaisista toiminnoista huomattavasti alentuneella teholla 
tai huomattavin vaikeuksin tai vain osaksi.
4 (  ) Pystyn suoriutumaan tavanomaisista toiminnoista vain pieneltä osin.
5 (  ) En pysty suoriutumaan lainkaan tavanomaisista toiminnoista.
Kysymys 10. Henkinen toiminta
1 (  ) Pystyn ajattelemaan selkeästi ja johdonmukaisesti ja muistini toimii täysin moitteet-
tomasti.
2 (  ) Minulla on lieviä vaikeuksia ajatella selkeästi ja johdonmukaisesti, tai muistini ei toi-
mi täysin moitteettomasti
3 (  ) Minulla on melkoisia vaikeuksia ajatella selkeästi ja johdonmukaisesti, tai minulla on 
jonkin verran muistinmenetystä
4 (  ) Minulla on suuria vaikeuksia ajatella selkeästi ja johdonmukaisesti, tai minulla on 
huomattavaa muistinmenetystä
5 (  ) Olen koko ajan sekaisin ja vailla ajan tai paikan tajua
KYSYMYS 11. Vaivat ja oireet
1 (  ) Minulla ei ole mitään vaivoja tai oireita, esim. kipua, särkyä, pahoinvointia, kutinaa 
jne.
2 (  ) Minulla on lieviä vaivoja tai oireita, esim. lievää kipua, särkyä, pahoinvointia, kutinaa 
jne.
3 (  ) Minulla on melkoisia vaivoja tai oireita, esim. melkoista kipua, särkyä, pahoinvointia, 
kutinaa jne.
4 (  ) Minulla on voimakkaita vaivoja tai oireita, esim. voimakasta kipua, särkyä, pahoin-
vointia, kutinaa jne.
5 (  ) Minulla on sietämättömiä vaivoja ja oireita, esim. sietämätöntä kipua, särkyä, pahoin-
vointia, kutinaa jne.
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KYSYMYS 12. Masentuneisuus
1 (  ) En tunne itseäni lainkaan surulliseksi, alakuloiseksi tai masentuneeksi.
2 (  ) Tunnen itseni hieman surulliseksi, alakuloiseksi tai masentuneeksi.
3 (  ) Tunnen itseni melko surulliseksi, alakuloiseksi tai masentuneeksi.
4 (  ) Tunnen itseni erittäin surulliseksi, alakuloiseksi tai masentuneeksi.
5 (  ) Tunnen itseni äärimmäisen surulliseksi, alakuloiseksi tai masentuneeksi.
KYSYMYS 13. Ahdistuneisuus
1 (  ) En tunne itseäni lainkaan ahdistuneeksi, jännittyneeksi tai hermostuneeksi.
2 (  ) Tunnen itseni hieman ahdistuneeksi, jännittyneeksi tai hermostuneeksi.
3 (  ) Tunnen itseni melko ahdistuneeksi, jännittyneeksi tai hermostuneeksi.
4 (  ) Tunnen itseni erittäin ahdistuneeksi, jännittyneeksi tai hermostuneeksi.
5 (  ) Tunnen itseni äärimmäisen ahdistuneeksi, jännittyneeksi tai hermostuneeksi.
KYSYMYS 14. Energisyys
1 (  ) Tunnen itseni terveeksi ja elinvoimaiseksi.
2 (  ) Tunnen itseni hieman uupuneeksi, väsyneeksi tai voimattomaksi.
3 (  ) Tunnen itseni melko uupuneeksi, väsyneeksi tai voimattomaksi.
4 (  ) Tunnen itseni erittäin uupuneeksi, väsyneeksi tai voimattomaksi, lähes ”loppuun pa-
laneeksi”.
5 (  ) Tunnen itseni äärimmäisen uupuneeksi, väsyneeksi tai voimattomaksi, täysin ”lop-
puun palaneeksi”.
KYSYMYS 15. Sukupuolielämä
1 (  ) Terveydentilani ei vaikeuta mitenkään sukupuolielämääni.
2 (  ) Terveydentilani vaikeuttaa hieman sukupuolielämääni.
3 (  ) Terveydentilani vaikeuttaa huomattavasti sukupuolielämääni.
4 (  ) Terveydentilani tekee sukupuolielämäni lähes mahdottomaksi.
5 (  ) Terveydentilani tekee sukupuolielämäni mahdottomaksi.
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Lue ensin läpi huolellisesti kunkin kysymyksen kaikki vastausvaihtoehdot. Merkitse rasti (x) 
sen vaihtoehdon kohdalle, joka parhaiten kuvaa nykyistä suolisäiliöleikkauksen jälkeistä suo-
len toimintaanne. Valitse kustakin kysymyksestä yksi, parhaiten tilannetta vastaava kohta.
Kokonaisuuden kannalta on tärkeää, että vastaisit kaikkiin kysymyksiin, vaikka muissa saa-
missasi kaavakkeissa on saman tyyppisiä kysymyksiä.
1. Kuinka monta kertaa suolenne on toiminut keskimäärin päiväaikaan viimeisen kahden 
viikon aikana? Ole hyvä ja valitse seuraavista yksi, parhaiten sopiva vaihtoehto.
 (  ) 4 kertaa tai vähemmän
 (  ) 5 kertaa
 (  ) 6 kertaa tai enemmän
2. Kuinka monta kertaa suolenne on toiminut keskimäärin öisin viimeisen kahden viikon 
aikana? Ole hyvä ja valitse seuraavista yksi, parhaiten sopiva vaihtoehto.
 (  ) ei kertaakaan
 (  ) kerran tai enemmän viikossa
 (  ) 2 kertaa tai enemmän yössä
3. Minulla on ollut kiire vessaan siten, etten ole pystynyt siirtämään ulostamista ulosta-
mistarpeen tultua yli 30min. 
 (  ) ei
 (  ) kyllä
4. Kärsin ulostamisvaikeudesta siten, että olen joutunut viettämään ulostamassa yli 15 min 
kerrallaan viimeisen kahden viikon aikana.
 (  ) ei
 (  ) kyllä 
5. Minulla on ollut ulosteen pidätyskyvyttömyyttä tai alusvaatteiden tahatonta tahriintu-
mista päiväaikaan viimeisen kahden viikon aikana? 
 (  ) ei
 (  ) kerran tai useammin viikossa
6. Minulla on ulosteen pidätyskyvyttömyyttä tai alusvaatteiden tahatonta tahriintumista 
öisin
 (  ) ei
 (  ) kerran tai useammin viikossa
7. Minulla on ollut kipua tai arkuutta peräaukon seudussa viimeisen kahden viikon aikana.
 (  ) ei 
 (  ) ajoittain
 (  ) jatkuvaa
8. Olen joutunut käyttämään suojasidettä päiväaikaan viimeisen kahden viikon aikana.
 (  ) ei
 (  ) kerran tai useammin viikossa
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9. Olen joutunut käyttämään suojasidettä öisin viimeisen kahden viikon aikana.
 (  ) ei
 (  ) kerran tai useammin viikossa
10. Olen joutunut välttämään tiettyjä ruoka-aineita, jotka vaikuttavat J-pussin toimin-
taan, viimeisen kahden viikon aikana.
 (  ) ei 
 (  ) kyllä
11. Olen joutunut käyttämään suolensisältöä muokkaavia lääkkeitä viimeisen kahden vii-
kon aikana.
 (  ) ei
 (  ) kyllä 
12. J-pussin toiminta on haitannut normaalissa päivätyössä käymistä tai muuta normaalia 
sosiaalista elämää viimeisen kahden viikon aikana. 
 (  ) ei
 (  ) kyllä
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Taudin aktiivisuuteen liittyvä kyselylomake (SCCAI)
Tämä kyselykaavake on laadittu selvittämään paksusuolen tulehduksen aktiivisuutta Sinulla 
tällä hetkellä. Merkitse kussakin kysymyksessä rasti (x) sen vaihtoehdon kohdalle, joka parhai-
ten vastaa omaa tilannettasi viimeksi kuluneiden kahden viikon aikana. 
1. Kuinka monta kertaa suolesi on toiminut keskimäärin päiväaikaan viimeisen kahden 
viikon aikana? Ole hyvä ja valitse seuraavista yksi, parhaiten sopiva vaihtoehto.
 (  ) 1–3 kertaa
 (  ) 4–6 kertaa
 (  ) 7–9 kertaa
 (  ) yli 9 kertaa
2. Kuinka monta kertaa suolesi on toiminut keskimäärin öisin kahden viimeisen viikon 
aikana? Ole hyvä ja valitse seuraavista yksi, parhaiten sopiva vaihtoehto. 
 (  ) Ei kertaakaan
 (  ) 1–3 kertaa 
 (  ) 4–6 kertaa
3. Onko ulostaminen on ollut pakonomaista siten, että on tullut kiire vessaan viimeisen 
kahden viikon aikana? Ole hyvä ja valitse seuraavista yksi, parhaiten sopiva vaihtoehto.
 (  ) ei kiirettä
 (  ) täytyy kiirehtiä
 (  ) täytyy päästä heti
 (  ) valuu housuihin
4. Onko ulosteissasi esiintynyt verta kahden viimeisen viikon aikana? Ole hyvä ja valitse 
seuraavista yksi, parhaiten sopiva vaihtoehto.  
 (  ) ei
 (  ) veriviiruja
 (  ) toisinaan kirkasta verta
 (  ) yleensä kirkasta verta
5. Yleistilani kahden viimeisen viikon aikana on ollut. Ole hyvä ja valitse seuraavista yksi, 
parhaiten sopiva vaihtoehto.
 (  ) erittäin hyvä
 (  ) hyvä
 (  ) huono
 (  ) erittäin huono
 (  ) sietämätön
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6. Onko Sinulla esiintynyt jotain seuraavista suolen ulkopuolisista sairauden ilmentymis-
tä? (Voi rastittaa useamman vaihtoehdon.)
 (  ) nivelsärky
 (  ) värikalvon tulehdus silmässä eli iriitti
 (  ) kyhmyruusu
 (  ) haavainen ihotulehdus eli pyoderma gangrenosum
 (  ) peräaukon haavauma
 (  ) peräaukon fisteli
 (  ) perianaalipaise
 (  ) suun aftat
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ABSTRACT
Background and Aims: Restorative proctocolectomy is the most common operation in 
patients with ulcerative colitis. The aim was to evaluate long-term changes in our operative 
treatment and early and late complications related to restorative proctocolectomy.
Material and Methods: The study comprised 352 (149 females) patients over 18 years 
of age with ulcerative colitis who underwent restorative proctocolectomy in 1985–2009 
median follow-up time of 5 years.
Results: The indication for surgery was active chronic colitis in 168 (47.7%), acute colitis 
in 159 (45.2%), and cancer or dysplasia in 25 (7.1%) patients. Ileal pouch-anal anastomosis 
was performed using hand-sewn anastomosis with mucosectomy in 283 patients and 
stapled anastomosis in 69. A shift from hand-sewn to stapler ileal pouch-anal anastomosis 
took place in 2005. Covering ileostomy was carried out in 133 (37.8%) patients. There 
were 82 (23.3%) J-pouch-related complications. The operative mortality was 0.3%. There 
were significantly fewer leakages and early re-operations when covering ileostomy was 
used than when it was omitted: 6.0% versus 16.4% (p = 0.004), 4.5% versus 11.9% (p = 0.02), 
respectively. There were more strictures in hand-sewn than in stapled ileal pouch-anal 
anastomoses (17.6% vs. 0%, p = 0.001). Pouchitis occurred at least once in 134 (38.1%) 
patients.
Conclusion: The ileal pouch-anal anastomosis technique used in restorative 
proctocolectomy had changed over the past years from hand-sewn to stapled anastomosis. 
Covering ileostomy seemed to protect against major complications. Pouchitis was the most 
common late complication.
Key words: Ulcerative colitis; ileal pouch-anal anastomosis; restorative proctocolectomy; complication
Correspondence:
Ilona Helavirta  
Department of Gastroenterology and Alimentary Tract 
Surgery  
Tampere University Hospital  
Teiskontie 35 33521 Tampere  
Finland 
Email: ilona.helavirta@staff.uta.fi
590540 SJS0010.1177/1457496915590540Restorative proctocolectomyI. Helavirta, H. Huhtala, M. Hyöty, P. Collin, P. Aitola
research-article2015
Original Article
I. Helavirta, H. Huhtala, M. Hyöty, P. Collin, P. Aitola74
INTRODUCTION
Restorative proctocolectomy (RPC) with ileal pouch-
anal anastomosis (IPAA) is the treatment of choice 
when surgical treatment in ulcerative colitis (UC) is 
needed (1). The operation is associated with consider-
able morbidity; leakage and pelvic sepsis are the most 
serious complications, occurring in 6%–25% of patients 
(2, 3). Pouchitis is the most common of the late compli-
cations; at least one episode is experienced within 
10 years after surgery in 25%–48% of patients (4–6); in 
3%–17%, pouch failure requiring permanent ileos-
tomy is inevitable (7–9).
The operative technique has gone through changes 
in recent decades. The use of covering ileostomy is rec-
ommended but not mandatory (10, 11). Stapled anas-
tomosis has in many cases replaced hand-sewn 
anastomosis (12).
The aim of this study was to evaluate the results of 
RPC in 352 consecutive patients operated for UC in 
1985–2009. Special focus was on the effects of the 
changed IPAA technique on early and late complica-
tions.
MATERIAL AND METHODS
All patients with UC who underwent RPC at Tampere 
University Hospital between March 1985 and 
December 2009 were identified in the hospital records; 
the total number of subjects was 352 (149 women, 
42.3%), median age of 36 years, range of 18–72. A data-
base was collected from patient files including details 
on patient history, operation technique, postoperative 
morbidity, and follow-up.
Indications for surgery were categorized into three 
groups: acute colitis resistant to conventional medical 
management, chronic colitis and the development of 
dysplasia, cancer or estimated high risk of progression 
to malignancy. Acute colitis was determined when 
urgent colectomy had to be performed. Chronic colitis 
included failure of medical treatment, corticosteroid 
dependent or resistant disease or active disease despite 
any treatment.
Early complications were defined as occurring 
within 30 days of the operation. Pelvic sepsis was pre-
sent when there was a leakage, pelvic abscess, or pel-
vic infected hematoma. Small bowel obstruction (SBO) 
was considered a complication when hospital stay 
exceeded the median 10 days in the whole series.
Late complications consisted of all problems 
recorded more than 30 days after the operation. The 
diagnosis of pouchitis was based on clinical signs and 
symptoms and occasionally on endoscopic and histo-
logical findings. Anastomotic stricture was considered 
a complication if it caused functional difficulties and 
the dilatation was needed. Pouch failure was defined 
as the need for a permanent ileostomy with or without 
pouch excision.
STATISTICAL ANALYSES
Grouped data are expressed as median and range. 
Chi-Square or Fisher’s exact test was used to assess 
differences in categorical variables. Statistical signifi-
cance was set at p ⩽ 0.05. Binary logistic regression 
analysis was used to determine the predictors of leak-
age. Results are shown as odds ratios (ORs) with their 
95% confidence intervals (CIs).
RESULTS
SURGERY
Indications for surgery were acute colitis in 159 
(45.2%), chronic colitis in 168 (47.7%), and cancer or 
risk of cancer in 25 (7.1%) patients. Colectomy was 
performed on 47.7% of patients prior to the IPAA pro-
cedure. During 1985–2005, nearly all IPAAs were 
hand-sewn with distal mucosectomy, and from 2005 
onwards the main technique was a stapled IPAA with 
a covering ileostomy. Before this, a covering ileostomy 
was performed only when considered necessary. A 
J-shaped reservoir was used in all cases. The types of 
operations and anastomoses performed are shown in 
Table 1. Four experienced surgeons performed 91% of 
the operations.
EARLY MORBIDITY
Pouch-related complications were the most common, 
occurring in 82 (23.3%) (Table 2); of these, altogether 61 
(17.3% of all) had pelvic sepsis, including 44 leakages. 
TABLE 1
Types of operations for ileal pouch-anal anastomosis (IPAA).
Number %
Type of operation
 Proctocolectomy + IPAA 98 27.8
 Proctocolectomy + IPAA + covering 
ileostomy
87 24.7
 Proctectomy + IPAA after colectomy 121 34.4
 Proctectomy + IPAA + ileostomy after 
colectomy
46 13.1
Type of anastomosis
 Hand-sewn 283 80.4
 Stapled 69 19.6
TABLE 2
Number of pouch-related complications.
Number % Hand-sewn/
stapler
Stoma/no 
stoma, n
Pouch-related 
complications
82 23.3  
 Leakage 44 12.4 39/5 8/36*
 Bleeding 8 2.3 8/0 0/8*
 Abnormal pain 5 2.3 5/0 2/3
 Fistula 3 0.8 3/0 1/2
 Stricture 1 0.3 0/1* 1/0
 Early pouchitis 4 1.1 4/0 1/3
  Infected hematoma 
or abscess
17 4.8 13/4 9/8
*Statistically significant.
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One patient (0.3%) died of postoperative bleeding; he 
was re-operated on to achieve hemostasis on the first 
postoperative day, but declined blood transfusions for 
religious reasons.
A total of 32 (9.1%) of the patients required re-oper-
ation due to complications. The indications were 
leakage in 25, hemorrhage in 2, SBO in 4, and perfora-
tion in 1. In all, 23 loop ileostomies were made in 
these re-operations, of which all but 2 were closed 
later; 1 permanent end-ileostomy was made due to a 
leakage.
A total of 81 (23%) patients were re-admitted to hos-
pital within the postoperative period. The reasons 
were fever in 22, abscess in 20, leakage in 11, dehydra-
tion in 9, SBO in 6, and miscellaneous reasons in 13.
There were significantly fewer leakages and early 
re-operations when covering ileostomy was used than 
when it was not used, 6.0% versus 16.4% (p = 0.004) 
and 4.5% versus 11.9% (p = 0.02), respectively (Fig. 1). 
In the logistic regression analysis, no single factor con-
stituted an independent risk for pelvic sepsis. 
Omission of covering stoma and high body mass 
index (BMI) were independent risk factors for leakage, 
ORs of 3.68 (95% CI: 1.61–8.42) (p = 0.002) and 1.11 
(1.01–1.21) (p = 0.03), respectively. When the patients 
without covering stoma were divided by BMI into 
four groups (<22, 22–24, >24–27, and >27), the most 
obese group were found to be at clearly higher risk of 
leakage, 6.5% versus 25.0% (p = 0.017).
Of the early complications, dehydration was the 
only which occurred significantly more frequently in 
the patients with covering stoma than in those with-
out stoma, 6.8% versus 0.0% (p < 0.001), respectively. 
The rate of early SBOs did not differ between these 
two groups, occurring in 6.0% and 5.9%.
Five of the covering ileostomies made were 
closed in another hospital. The median time from 
IPAA to ileostomy closing operation was 113 days 
(range: 30–912). Of the 125 cases closed in our unit, 
the median hospital stay was 7 days. The overall 
morbidity related to closing of covering stomas was 
31.6% (n = 42), the most common being SBO in 16.8% 
patients (n = 25); SBO was considered a complica-
tion when it led to longer hospital stay than median 
or re-admission. A total of 17 (11.4%) patients had 
an infection complication after ileostomy closure, 4 
of whom (3.0%) experienced leakage; all patients 
with leakage needed re-operation. Three of the cov-
ering ileostomies were never closed before pouch 
excision.
LONG-TERM COMPLICATIONS
The median follow-up time was 5 years (range: 
1 month–24 years). Late complications are presented in 
Table 3. The most common of these was pouchitis, 
occurring in 134 (39.3%) patients. Of these 106 (76.3%) 
experienced more than one episode. A total of 45 
(13.2%) patients had at least one episode of SBO; 17 
(37.8%) of them underwent a laparotomy and adhesi-
olysis due to obstruction. The use of covering ileos-
tomy and subsequent closing operation did not result 
in more late SBOs than omitting the temporary ileos-
tomy, occurring in 14.6% versus 12.4% (p = 0.6), respec-
tively. SBO occurred in 15.9% when IPAA was 
constructed later after colectomy, and in 10.7% when it 
was done at the same time (p = 0.16).
Patients with hand-sewn anastomosis had signifi-
cantly more anastomotic strictures than those with 
stapled anastomosis (17.6% vs. 0%, p = 0.001).
A total of 41 (12.2%) patients underwent pouch 
excision, and 1 patient was satisfied with the diverting 
ileostomy constructed due to peritonitis. One of the 
patients had the pouch removed due to chronic pouch-
itis 20 years after the primary operation, and histologic 
sample revealed mucinotic rectal cancer, of which the 
Fig. 1. Influence of covering ileostomy on leakages (p = 0.004) and early re-operations (p = 0.02).
I. Helavirta, H. Huhtala, M. Hyöty, P. Collin, P. Aitola76
patient died 2 years later; in this case, the anastomosis 
was performed by hand-sewn mucosectomy.
DISCUSSION
The IPAA operation used should offer low postopera-
tive mortality and an acceptable rate of complica-
tions. Loop ileostomy is not an ideal form of stoma for 
the patient to cope with, and it is sometimes associ-
ated with considerable morbidity. The only signifi-
cant difference in early complications between 
covering stoma and omitting it in our study was 
dehydration; and the number of patients (n = 9, 6.8%) 
was low. However, some complications extended the 
hospital stay. On the other hand, most patients with 
SBO were treated conservatively after the closing 
operation, and the most serious complication, leak-
age, was rare (3%). The morbidity of closing opera-
tions in our hospital was at acceptable level when 
compared to the literature (13).
Some studies recommend ileostomy only in selected 
cases, since there were no differences in the morbidity 
rate or pouch-related complications when ileostomy 
was used or not (10, 14). A meta-analysis of this con-
cluded that the omission of covering ileostomy might 
be justified in patients defined as low risk, but low risk 
was not well defined (15). The study by Kiran et al. 
(16) aimed to identify factors which predict septic 
complications, and making or omitting stoma had no 
influence.
Altogether, 18.5% of our patients had experienced 
pelvic sepsis and leakage occurred in 12.5%. In the lit-
erature, the pelvic sepsis figures range from 3% to 25% 
(2, 3, 5, 7, 17–19) depending on the definition. About 
one-third (6) of the patients with pelvic sepsis were re-
operated on and the others were treated conservatively. 
Our finding advocates the use of loop ileostomy, as 
patients with covering ileostomy had significantly 
fewer leakages and early relaparotomies. This is in line 
with the recent European Crohn’s and Colitis 
Organisation (ECCO) recommendation, where the use 
of loop ileostomy is advocated except in highly selected 
cases (20). The study by Mennigen et al. (11) supports 
our finding: they likewise showed that loop ileostomy 
reduced pouch-related septic complications and the 
need for early relaparotomies.
SBO is the late complication of IPAA which leads most 
often to laparotomy. It is thought to be caused especially 
by pelvic adhesions. In our series, the frequency of early 
SBO was 5.6% and of late SBO 13.2%. The corresponding 
figures in the literature are 7.5% and 25% (17). In our 
series, 20% of early and 35.6% of late SBOs required 
relaparotomy; the respective percentages in the literature 
being 3.2%–8.7% and 22.9%–31.4% (17, 21, 22). The inci-
dence of SBO has been reported to increase with time 
after operation, and has been shown to be more frequent 
when covering ileostomy is used (22). Our data do not 
support this.
Stapled technique in anastomosis for IPAA has 
been shown to result in better nocturnal continence 
than hand-sewn anastomosis and is also easier to per-
form (12). According to some studies, stapled tech-
nique results in fewer septic complications than 
hand-sewn technique (23, 24). A systematic review of 
dysplasia after IPAA in 2040 patients showed a pooled 
prevalence of dysplasia of 1.13% in the pouch, the anal 
transitional zone, and the rectal cuff. The only identi-
fied risk factor for subsequent dysplasia in the rectal 
cuff with IPAA was the finding of dysplasia in the sur-
gical specimen (25). It is noteworthy that even hand-
sewn mucosectomy is not complete in excising the 
mucosa of the transition zone (12). Because of the 
accumulating data in favor of stapler anastomosis as 
mentioned above, we shifted from making hand-sewn 
anastomoses to mainly stapler anastomoses around 
the year 2005.
We still perform hand-sewn anastomosis with 
mucosectomy, when the patient is operated on for can-
cer or when there is dysplasia in the rectum. The 
known risk factors for colorectal cancer in patients 
with inflammatory bowel disease are family history, 
extensive colitis with active endoscopic or histologic 
prolonged inflammation, primary sclerosing cholan-
gitis, and pseudopolyposis (26); in these cases, hand-
sewn anastomosis might be recommended, but the 
issue requires further research.
In this study, one cancer was found after IPAA, and 
the anastomosis was hand-sewn. Hand-sewn anasto-
moses resulted in significantly more late strictures 
than did stapled anastomoses. The same has also been 
shown in a study comprising 3109 patients (23).
Pouchitis was clearly the most common late com-
plication, 134 (39.3%); 23% had experienced only one 
episode. These figures are in concordance with other 
studies reporting pouchitis in 23.5%–48% (3, 5–7, 17).
The main limitations of this study were its retro-
spective character and the lack of annual follow-up 
data. The postoperative protocols changed in our hos-
pital during the study period, rendering it challenging 
to compare the different groups. Also, the different 
follow-up periods of the two groups of patients with 
different types of anastomoses made it impossible to 
compare the long-term outcome between these 
groups.
In conclusion, serious acute complications in RPC 
were comparable with previous studies. We favor the 
routine use of covering ileostomy to avoid the most 
critical complications considering the functional out-
come and long-term success rate, pelvic sepsis, and 
leakage. The stapled anastomosis technique is favored 
over the hand-sewn technique, except in selected cases 
with high risk of dysplasia or cancer. Pouch-related 
complications are most common in the long-run.
TABLE 3
Late complications in the series.
Number % Hand-sewn/
stapler
Stoma/
no stoma
Small bowel obstruction 45 12.8 41/4 18/27
Fistula or abscess 42 12.6 37/5 12/30
Anastomotic stricture 49 14.5 49/0* 16/33
Ventral or parastomal 
hernia
12 3.6 7/5* 4/8
Pouchitis 134 39.3 117/17* 41/93
*Statistically significant.
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ABSTRACT
Background and Aims: Patients undergoing restorative proctocolectomy have often suffered 
from active ulcerative colitis which should be remembered when assessing quality of life 
after operation. The aim of this study was to explore health-related quality of life after 
restorative proctocolectomy in those with poor or good pouch function and to compare 
that to patients with active or inactive ulcerative colitis and to the general population.
Material and Methods: Altogether, 282 restorative proctocolectomy patients were 
investigated. The control group comprised 408 ulcerative colitis patients from the local 
register. Generic 15D and disease-specific inflammatory bowel disease questionnaire 
health-related quality of life instruments were used. Population-based data were available 
for 15D. Pouch function was evaluated with Öresland score and colitis activity with simple 
clinical colitis activity index.
Results: 15D results showed that patients with good pouch function had health-related 
quality of life similar to that of the general population. Health-related quality of life with 
inflammatory bowel disease questionnaire was equally good in patients with good pouch 
function (n = 131; 70%) and inactive colitis (n = 95; 63%), and equally impaired in patients 
with poor pouch function (n = 56; 30%) and active colitis (n = 18; 12%).
Conclusion: The majority of patients had health-related quality of life comparable to that 
in general population. Most patients with active ulcerative colitis are likely to improve 
their health-related quality of life after successful surgery. These findings are important 
when informing colitis patients about life after surgery.
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Fig. 1. Flow chart of the formation of the study and the control 
group.
INTRODUCTION
Restorative proctocolectomy (RPC) is the standard 
operation for patients with active ulcerative colitis 
(UC) (1). With successful surgery, patients can avoid a 
permanent stoma and are able to live a normal life. 
Health-related quality of life (HRQoL) is essential in 
evaluating the long-term results of the operation, since 
RPC may be associated with complications and func-
tional failures (2, 3).
Many studies have shown that HRQoL in RPC 
patients has been comparable to that in general popu-
lation (4–6). On the other hand, poor functional results 
are associated with impaired quality of life (7–9), 
which again may influence these patients’ daily lives. 
It must be noted that patients undergoing RPC usually 
suffer from active colitis and HRQoL after the opera-
tion is important in this group.
Here, we compared results separately to non-oper-
ated colitis patients with active or inactive disease and 
similarly in RPC patients with good or poor functional 
result. This information about functional outcome and 
quality of life is valuable when the physician is dis-
cussing surgical treatment with the patient.
MATERIAL AND METHODS
PATIENT SELECTION
This cross-sectional study included all consecutive 352 
patients with UC who underwent RPC at the Tampere 
University Hospital between 1985 and 2009; the sub-
jects were identified in the hospital records using the 
International Classification of Diseases, 9th Revision 
(ICD-9) and International Classification of Diseases, 
10th Revision (ICD-10) codes for UC and official codes 
for the operations performed. A database to form an 
RPC registry was collected from patient files including 
details on patient history, operation technique, postop-
erative morbidity, and follow-up. Of these, 282 had 
their pouch in function and could be located and they 
were sent questionnaires. Data were collected between 
October 2012 and May 2013. The control group con-
sisted of 408 age- and sex-matched UC patients from 
the local inflammatory bowel disease (IBD) register. It is 
a prospective register for all adult patients with IBD. 
Cases were collected retrospectively before 1986 and 
after that prospectively. The age and gender distribu-
tions of the study group and the control group were 
similar. See the selection path for the groups in Fig. 1. 
The clinical data of the study patients are retrieved from 
these registries mentioned above.
QUESTIONNAIRES
The questionnaires were sent by mail, and one reminder 
was sent to the non-respondents. Two different instru-
ments were used to measure HRQoL; one generic (15D) 
and one disease specific (inflammatory bowel disease 
questionnaire (IBDQ)). Pouch function was assessed by 
Öresland score (10) and disease activity in non-operated 
subjects with UC by simple clinical colitis activity index 
(SCCAI) (11). The 15D instrument is Finnish, and the 
other questionnaires were translated from English into 
Finnish by official translators and a back-translation into 
English was done to confirm the linguistic accuracy of 
the translation.
The 15D is a generic self-administered measure of 
HRQoL. The instrument can be used both as a profile 
and as a single score measure. The questionnaire 
includes 15 dimensions: mobility, vision, hearing, 
breathing, sleeping, eating, speech, excretion, usual 
activities, mental function, discomfort and symptoms, 
depression, distress, vitality, and sexual activity. For 
each dimension, respondents choose one of the five 
ordinal levels best describing their current state of 
health. The valuation system is based on an applica-
tion of multi-attribute utility theory. The single-index 
score (15D score), reflecting overall HRQoL on a 0–1 
scale (1 = full health, 0 = being dead) and similarly, the 
dimension level values, reflecting the goodness of the 
levels relative to no problems on the dimension = 1 
and to being dead = 0, were calculated from the ques-
tionnaire using a set of population-based preference 
or utility weights. Mean dimension level values were 
used to draw 15D profiles. A difference of ≥0.03 in 15D 
score was considered clinically important in the sense 
that a person can, on average, feel the difference (18). 
The 15D has been used with IBD patients before (12). 
The 15D data for general population came from the 
National Health 2011 Survey representing Finnish 
population aged 18 and above. This sample (n = 4763) 
was weighted to reflect the age and gender distribu-
tion of the patients (13).
A disease-specific IBDQ is a widely used standard-
ized 32-item questionnaire, which addresses four differ-
ent aspects of life: digestive symptoms, social functioning, 
emotional status, and systemic symptoms. The question-
naire has been validated in patients undergoing RPC for 
UC (14). It has been translated into Finnish and used in 
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IBD (15). Total IBDQ score ranges from 32 to 224, a higher 
score indicating better quality of life.
Pouch function was assessed by Öresland score 
(10). It includes items about the number of day-
time and night-time bowel movements, inconti-
nence for liquid or solid stools, pad usage, urgency, 
diet, medication, and social handicap; these ratings 
are summarized into a single score (range, 0–15; 15 
being worst). The questionnaire was translated into 
Finnish and was used with the permission of the 
developer (10). This questionnaire has been tailored 
for RPC and used in previous studies to elicit pouch 
function and HRQoL in UC. In the study by 
Berndtsson et al., poor Öresland scores correlated 
negatively with HRQoL results (7). The authors 
classified the score indicating very good 0–4, good 
5–7, or poor pouch function 8–15. We decided to 
combine the groups with very good and good 
pouch function and hence the limit was set at a 
score of 8.
Disease activity of UC was measured using the 
SCCAI (11). A score of ≤2 was defined as remission, 
3–4 as mild or moderately active disease, and ≥5 as 
severely active disease (16, 17).
STATISTICS
The data were analyzed using SPSS (IBM Corp, 
released 2012. IBM SPSS Statistics for Windows, ver-
sion 21.0; IBM Corp, Armonk, NY).
The 15D index was chosen to be the main parame-
ter with which the power calculations were made in 
the planning phase. With 15D difference ≥0.03 can be 
detected by an individual (18). Power calculations 
have been made using PS program difference being 
0.03, power 80%, and statistical difference 0.05. In this 
way, both groups need to include 142 patients.
For categorical variables, the results are given as 
frequencies and percentages and for continuous vari-
ables as means and standard deviation or as medians. 
Comparisons between different patient groups were 
tested with chi-square test and in IBDQ scores with 
Kruskal–Wallis test. Independent samples t-test was 
used to compare the mean 15D scores of the patients 
and the age- and gender-standardized sample of 
general population. P-values ≤ 0.05 were considered 
statistically significant.
RESULTS
The gender distribution of the respondents was 47% 
of women in the study and 46% in the control group. 
The median age was 53 years in the study group and 
55 years in the control group. The demographic data 
on both groups for responders and non-responders 
are shown in Table 1.
RPC PATIENTS
Of the 352 patients operated on between 1985 and 
2009, pouch failure (pouch excision or permanent ile-
ostomy without excision) had occurred in 42 and 
were excluded, 3 could not be reached and 25 had 
died (Fig. 1). Of the eligible 282 patients, 187 (66.3%) 
returned the questionnaires; 87 (67%, n = 130) of the 
women and 100 (66%, n = 152) of the men. The median 
age of the patients was 53 (range, 23–81) years, and 
the median follow-up time after RPC was 13 (range, 
4–28) years.
The 95 RPC patients who did not return the ques-
tionnaire were on average three and a half years 
younger than those who did respond; there was no 
gender difference between respondents and non-
respondents. When we compared the clinical data 
concerning the operation, we found that there was no 
significant difference in leakage or pelvic sepsis 
between the respondents and non-respondents.
Altogether, 131 (70%) of the patients had a well-
functioning pouch with a score of <8, and 56 (30%) 
had a poor pouch function.
UC PATIENTS
In non-operated UC patients, 153 (37.5%) of 408 
returned the questionnaire. Seventy-one (46%) of them 
were women and 82 (54%) men. The median age of the 
patients was 55 (range, 24–81) years. Of the non-oper-
ated UC patients 95 (62.1%) were in remission, 39 
(25.5%) had mild to moderately active disease, and 18 
(11.8%) severely active, as defined by SCCAI.
TABLE 1
Characteristics of RPC and the control UC patients and also the non-respondents.
Number of 
patients
Female, 
n (%)
Age at survey, 
years, median 
(range)
Time from 
diagnosis, years, 
median (range)
SCCAI, n (%)
 ≤2 3–4 ≥5
Non-operated patients 153 71 (46) 55 (24–81) 20 (6–48) 95 (62) 39 (25) 18 (12)
Non-respondents 255 112 (44) 49 (25–79) 21 (6–48)  
 
 
Time from 
operation
Öresland score, n (%)
<8 ≥8
RPC patients 187 87 (47) 53 (23–81) 13 (4–28) 131 (70) 56 (30)
Non-respondents 95 43 (45) 48 (24–89) 12 (3–27)  
SCCAI: simple clinical colitis activity index; RPC: restorative proctocolectomy.
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15D SCORES
The mean 15D score of the RPC patients undergoing 
surgery was lower (0.891 (0.097)) than that of general 
population (0.928 (0.077); p < 0.001). The RPC patients 
scored statistically significantly lower on 8 of the 15 
dimensions compared to the age- and gender- 
standardized sample of general population: sleeping, 
usual activities, excretion, discomfort and symptoms, 
depression, distress, vitality, and sexual activity (Fig. 
2A). In RPC patients with well-functioning pouches, 
the only significantly decreased score was in excre-
tion (Fig. 2B).
IBDQ SCORES
Fig. 2A shows that HRQoL was equally good in 
patients with good pouch function and inactive UC 
when measured by disease-specific IBDQ and also 
equally impaired in those with poor pouch function 
and active UC.
The IBDQ subscores for the different groups are 
presented in Table 2.
Patients with good pouch function showed better 
results in all subscores than those with active colitis 
(p < 0.001). There was no difference between groups 
when divided by the indication for surgery (p = 0.135–
0.850).
The IBDQ scores for subgroups of different indica-
tions for patients undergoing surgery compared to UC 
of different disease activity are shown in Fig. 3B. Fig. 
3C shows the IBDQ scores of operated patients with 
different time from operation.
There was no difference in HRQoL after surgery in 
different indications or time from operation. The 
scores were lower for RPC patients for any indication 
for surgery or time from operation than UC patients in 
remission but higher than UC patients with active dis-
ease.
DISCUSSION
This study investigated HRQoL using generic (15D) 
and disease-specific (IBDQ) questionnaires in a large 
cohort of patients operated on at a single institution 
within a period spanning over two decades. The main 
finding of this study was that RPC patients with a 
well-functioning pouch achieved HRQoL similar to 
that in general population and UC patients with their 
disease in remission or mild to moderate activity.
HRQoL has previously been reported to improve 
after RPC and reach the level of that in general pop-
ulation (4–6), although the results are inconsistent 
(19, 20). In a recent Finnish multicentre study HRQoL 
was impaired compared to the general population. 
This study also aimed to identify factors for poor 
outcome and found older age at time of operation 
and preoperative hypertension to be significant pre-
dictors (21). In this study, most (n = 131,70.1%) of the 
RPC patients had well-functioning pouch. Well-
functioning pouch was associated with good 
HRQoL, and therefore, the majority of RPC patients 
were satisfied with their lives after surgery. Poor 
functional results of the pouch have been associated 
with low HRQoL (7–9, 22). This was also shown in 
this study. This is something about which we can 
inform the patients preoperatively even though we 
do not know the reliable risk factors to identify 
patients prone to poor pouch function or pouch fail-
ure before surgery (23, 24).
UC patients with only mildly active disease or the 
disease in remission reported quality of life equally as 
good as that of RPC patients with well-functioning 
pouch. The quality of life scores were equally poor in 
patients with poorly functioning pouch or severely 
active UC. An Italian study showed similar results: 
UC in remission showed an overall QoL similar to that 
of uncomplicated RPC patients, while the same two 
groups of patients with mild clinical activity had an 
overall QoL score similar to those of patients with 
complicated RPC (25). A recent study also showed that 
even though RPC patients reported higher bowel 
movement frequency than patients treated with anti-
TNF (tumor necrosis factor), the RPC patients reported 
better outcomes for general HRQoL (26).
The patients who are considered for operative treat-
ment are those with active acute severe colitis or med-
ically refractory disease or those with dysplasia or 
cancer. There was no difference in HRQoL when com-
paring study patients divided by indication. But, as 
we can see in Fig. 3B, patients in remission undergo-
ing surgery due to dysplasia or cancer were likely to 
experience deterioration in HRQoL, whereas patients 
operated on for active disease experience an improve-
ment in HRQoL after successful surgery. For dysplasia 
patients, we should emphasize the fact that with sur-
gical treatment potentially life-threatening disease 
Fig. 2. (2A) 15D scores of all restorative proctocolectomy patients 
with ileal pouch (n = 187) compared to general population 
n = 4762 and (2B) scores for well-functioning pouches (n = 131) in 
comparison to the population.
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will be treated, and yet, one can in most cases perform 
ileal pouch surgery with moderately good and stable 
HRQoL without permanent ileostomy.
The long-term results are important, since most of 
the patients undergoing surgery are young; the median 
follow-up time of 13 (range, 4–28) years in this study 
TABLE 2
IBDQ scores and subscores of patients undergoing surgery for different indications, pouch function groups, and control colitis patients for different 
disease activity groups.
Mean scores (MD) Total score Bowel disorder Emotional function Systemic symptoms Social function
Patients undergoing surgery
Indication
 Acute colitis (n = 79) 170.3 (36.8) 5.3 (1.0) 5.4 (1.3) 5.1 (1.3) 5.7 (1.4)
 Medically refractory (n = 93) 165.9 (35.7) 5.0 (1.1) 5.3 (1.2) 4.6 (1.3) 5.9 (1.2)
 Cancer or risk of cancer (n = 15) 172.3 (33.3) 5.3 (0.7) 5.3 (1.4) 4.8 (1.1) 6.4 (0.7)
Pouch function
 Good, score <8 (n = 131) 181.7 (27.1) 5.6 (0.7) 5.6 (1.0) 5.1 (1.1) 6.3 (0.9)
 Poor, score ≥8 (n = 56) 136.1(34.2) 4.2 (1.0) 4.2 (1.2) 3.8 (1.2) 4.9 (1.5)
Colitis patients not undergoing surgery
 UC in remission (n = 95) 199.3 (16.8) 6.3 (0.6) 6.2 (0.6) 5.7 (0.8) 6.8 (0.4)
 UC mildly active (n = 39) 173.4 (25.0) 5.4 (0.8) 5.4 (1.0) 4.7 (1.1) 6.2 (0.8)
 Active UC (n = 18) 133.7 (38.3) 4.1 (1.3) 4.1 (1.2) 3.7 (1.3) 4.6 (1.6)
UC: ulcerative colitis.
Fig. 3. IBDQ total scores in different subgroups of patients with ileal pouch or ulcerative colitis (UC) compared to non-operated patients 
for different disease activity groups. The score limits for each subgroup have been described in the Methods section; pouch function was 
measured by Öresland score and the activity of colitis by SCCAI score. (A) IBDQ total scores for good and poor functioning pouches. (B) 
IBDQ total scores in different subgroups of indication for surgery. (C) IBDQ total scores on subgroups on how much time had passed 
since operation.
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gives a good perspective on this. Quality of life was not 
dependent on the time elapsing since the operation.
A limitation of this study was the large number of 
patients who did not return the questionnaires. 
Response rates have declined in Finland in recent dec-
ades both in men and women in all age groups, faster 
among men and in younger age groups (27). The non-
response rate was high especially in non-operated UC. 
Nevertheless, it was possible make comparisons 
between patients with active and inactive UC, as we 
had enough patients in each activity group. 
Furthermore, there was no gender difference between 
operated and non-operated colitis patients, and the 
median age was almost the same. For comparison, in 
the entire colitis register, 45% were women, that is, the 
same percentage as in this study. The non-responders 
in RPC group were 3 years younger than the respond-
ers. Although younger patients have had slightly bet-
ter functional results, we assume that this small 
difference did not influence the results significantly. 
Pelvic inflammatory complications may impair the 
functional outcome (28, 29). The respondents and non-
respondents did not differ in leakage or pelvic sepsis. 
Therefore, we assume that the functional result that we 
used on dividing the RPC groups was valid. We did 
not investigate RPC patients who had experienced 
pouch failure. It would have not been possible to study 
the HRQoL before and after the pouch failure, which 
we think would have given the full picture. We did not 
include the patients undergoing permanent ileostomy. 
The number of such patients was low, including mostly 
elderly patients with a poor sphincter function and do 
not have RPC as an option. We did not have individual 
information about pre- and postoperative HRQoL. 
However, the results of our study show the same trend 
as studies with preoperative HRQoL data of how 
HRQoL improves after surgery (4, 6).
In conclusion, this study showed that successful 
RPC surgery for UC affords the majority of patients 
good and stable functional results. This again enables 
good long-term HRQoL, being comparable to that in 
the general population and in UC patients in remis-
sion. In the case of poor pouch function, quality of 
life remains at the same level to that in active UC. On 
the other hand, the surgery removes the disease-car-
rying colon, eliminating several risks, such as bleed-
ing or cancer development, and in most patients, 
burdensome and expensive medications can be dis-
continued. Nevertheless, our results are important 
when counseling the patients before the operation.
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